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Retinal Vascular Reactivity to Incremental Hyperoxia During 
Isocapnia 
Purpose 
Systemic hyperoxia has been induced using inspired gases in many studies to investigate vascular 
reactivity in the retinal vasculature. Technical limitations in the past resulted in inadequate control of 
systemic partial pressures of O2 and CO2, the latter of which tended to decrease secondary to induced 
hyperoxia. Recent development of a computerized gas delivery instrument has enabled the specific 
control of end-tidal CO2 (ETCO2) and fractional expired O2 (FeO2), independent of each other and of 
minute ventilation. The specific aims of each chapter are as follows:  
Chapter 3: To compare the magnitude and variability of the retinal vascular reactivity response to an 
isocapnic hyperoxic stimulus delivered using a manually-operated method to the newly developed 
computer-controlled gas sequencer.  
Chapter 4: To investigate the retinal hemodynamic response to incremental changes in hyperoxic 
stimuli during isocapnia.  
 
Methods 
Chapter 3: Ten young, healthy adults inhaled gases in a sequence of normoxic baseline, isocapnic 
hyperoxia, and normoxic recovery, using both gas delivery systems in random order.  
Chapter 4: Twelve healthy, young adults participated in a gas protocol consisting of 4 phases at 
varying fractional expired oxygen levels (FeO2): baseline (15%), hyperoxia I (40%), hyperoxia II 
(65%), and recovery (15%). End-tidal carbon dioxide (ETCO2) was maintained at an isocapnic level 
(~ 5%) throughout the experiment.  
In both Chapters 3 and 4, blood flow was derived from retinal arteriolar diameter and simultaneous 
 
iv 
blood velocity measurements of the superior temporal arteriole, acquired at 1-minute intervals during 
each of the phases of the gas protocol.  
 
Results 
Chapter 3: There was no interaction effect between the phases and gas delivery methods (p = 0.7718), 
but ETCO2 was significantly reduced during hyperoxia (p = 0.0002) for both methods. However, the 
magnitude of change in ETCO2 was physiologically insignificant i.e. <1%. The two systems differed 
in terms of FeO2 during hyperoxia, at a level of 85.27 ± 0.29% for the manual method, and 69.02 ± 
2.84% for the computer method (p < 0.05). Despite this difference in oxygen concentrations, there 
was no difference in the vascular reactivity response for diameter (p = 0.7756), velocity (p = 0.1176), 
and flow (p = 0.1885) for equivalent gas phases between the two gas delivery systems. The inter-
subject variability of retinal hemodynamic parameters was consistently lower using the computer-
controlled gas sequencer.  
Chapter 4: Repeated measures ANOVA showed that there were significant influences of incremental 
changes in FeO2 on arteriolar diameter (p < 0.0001), blood velocity (p < 0.0001), and blood flow (p < 
0.0001) in the retina. Paired t-tests of these retinal hemodynamic parameters during each phase in the 
gas sequence showed they were significantly different (p < 0.05) from each other, with the exception 
of baseline and recovery values. Incremental increases in FeO2 caused a linear decrease in group 
mean arteriolar diameter (R2 = 1, p = 0.002), group mean blood velocity (R2 = 0.9968, p = 0.04), and 
group mean blood flow (R2 = 0.9982, p= 0.03).  
 
Conclusions 
Chapter 3: Inter-subject variability for virtually all retinal hemodynamic parameters was reduced 
using the computer-controlled method, presumably due to a higher degree of gas control. However, 
 
v 
care needs to be exercised in the interprtetation of these results due to the relatively small sample size. 
A similar retinal hemodynamic response to isocapnic hyperoxia was induced using the two gas 
delivery systems, despite different levels of maximal FeO2. 
Chapter 4: Isocapnic hyperoxia elicits vasoconstriction and the reduction of retinal arteriolar blood 
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Literature Review: The Physiology of Retinal Blood Flow 
1.1 Anatomy and Physiology of Retinal Blood Flow 
1.1.1 The Anatomy of Retinal Blood Supply 
The blood supply to structures within the orbit arises from the ophthalmic artery, which originates from 
the internal carotid artery. Two separate blood supplies fulfill the nutritional and waste removal needs of 
the retina: these are the choroidal and retinal circulations, which are separated by the retinal pigment 
epithelial layer1;2.  
 
Arising from the ophthalmic artery within the orbit, the central retinal artery (CRA) supplies 
approximately the inner two-thirds of the retina. The CRA pierces the optic nerve approximately 10-15 
mm behind the globe, running parallel with the central retinal vein within the optic nerve 1. It passes 
through the lamina cribosa entering the optic disc just nasal to centre and branches superiorly and 
inferiorly.  These branches divide into nasal and temporal branches, and continue to bifurcate within the 
retinal nerve fibre layer below the transparent internal limiting membrane to supply the quandrants of the 
retina 3.  
 
The outer layers of the retina are supplied by the highly vascularized choroidal circulation, derived from 
the ophthalmic artery via branches of the long posterior ciliary artery, short posterior ciliary artery, and 
anterior ciliary artery. Specifically, the short posterior ciliary artery supplies the posterior choroid, while 
the long posterior ciliary artery and anterior ciliary artery supply the anterior choroid and the circle of the 
iris. It is composed of three vascular layers: the choriocapillaris lies internally, followed by Sattler’s layer 
with medium-sized vessels, and Haller’s layer with large veins. The anatomical border between the retina 
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and the choroid is Bruch’s membrane 4. Adjacent to Bruch’s membrane, the retinal pigment epithelium 
acts as the blood-retina barrier and selectively transports nutrients and waste between the choriocapillaris 
and the neural retina due to its avascular nature5. The retinal capillaries, unlike those in other capillary 
beds in the body, consist of unfenestrated endothelial cells joined together by zonulae occludentes (tight 
junctions), further contributing to the blood-retina barrier. This prevents vascular leakage into the retina 
and is important for protecting it against infection and the potentially damaging effects the body’s 
immune system. The blood retina barrier is compromised in diseases such as diabetic macular edema 6;7 
and acquired immunodeficiency syndrome (AIDS) 8.  
 
The choroidal circulation has many distinctions from the retinal circulation. Traditionally, it was thought 
that the choroidal circulation does not exhibit autoregulation whereas the retina is autoregulated 3. 
However, more recent evidence would suggest that autoregulation does occur in the choroid, though not 
as efficiently as compared to the retina 9-11.  At 18 mL/min per gram of tissue, the choroid carries 85% of 
the blood flow volume in the eye, whereas the retina carries only 0.5 - 1.7 mL/min per gram of tissue due 
to relatively sparse distribution of retinal vessels 12;13. A high blood flow rate in the choroid is thought to 
have a thermoregulatory function; blood flowing through the choroid dissipates the heat generated by 
phototransduction in the neural retina 12. The high and low blood flow rates of the choroid and retina 
respectively leads to a low arteriovenous pO2 difference (3%) in the choroid, and a larger arteriovenous 
pO2 difference (38%) in the retina since oxygen extraction is proportional to the rate of blood flow; the 
fact that the retina is also the most metabolically active tissue in the body further contributes to the large 
arteriovenous pO2 difference 3;12.  Furthermore, the terminal branches of the retinal arteries do not 
anastomose with other arteries, and are described as end-arterial in nature. Consequently, the inner retina 
has a low capacity to tolerate interruption to the blood supply14, making retinal blood flow an important 
 
3 
area of research 2;15. Disruption of retinal blood flow has been implicated in sight-threatening conditions 
including glaucoma 16;17 and diabetic retinopathy 18-21. 
 
Blood leaves the retina through the central retinal vein, which lies with the central retinal artery. Like 
other tributaries of the ophthalmic veins, the central retinal vein has no valves so blood flow is determined 
by pressure gradients. The central retinal vein either joins the superior ophthalmic vein or drains directly 
into the cavernous sinus. The choroid is drained via the vortex veins 22. 
 
1.1.2 Structure of Retinal Vessels 
The retinal vasculature is highly specialized in maintaining local control of blood flow. Histologically, 
retinal capillaries are composed of a single layer of unfenestrated, non-porous endothelium surrounded by 
an interrupted layer of pericytes, and a basement membrane. Tight junctions between the endothelial cells 
prevent vascular leakage into the neural retina (as described in 1.1.1). The retinal arterioles and venules 
are also composed of three layers, but a smooth muscle layer is present in place of the pericytes 23. While 
venules have only a single or double layer of smooth muscles, the number of smooth muscle layers found 
in arterioles is proportional to the vessel calibre, ranging from a few to more than 10 layers. Smooth 
muscle cells in the arteriolar wall are the primary contractile elements that regulate blood flow to maintain 
retinal perfusion and, to a lesser extent, pericytes in the capillary wall further “fine tune” local flow. Both 
smooth muscle cells and pericytes facilitate blood flow through their contractile function in response to 
vascular endothelium-derived mediators and other metabolites12. As with other vascular beds within the 
body, the arterioles are “resistance vessels” through which blood is released into the capillaries, which 
mediate exchange of gases, nutrients, and wastes with the tissue “exchange vessels”. 
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1.2 Blood Flow 
1.2.1 Ohm’s Law 
Blood flow is the quantity of blood flowing through a given segment of a blood vessel in the general 
circulation in a given period of time. Blood flow (Q) through a vessel is determined by a pressure gradient 
(ΔP) and vascular resistance (R). The pressure gradient is the pressure difference between the two ends of 
the vessel, this is the force that propels the blood. Vascular resistance is the force opposing the pressure 
gradient as a result of friction of the vessel wall. These two factors are related by Ohm’s Law. 
 
R
PQ Δ=  (1.1)  
1.2.2 Vascular Resistance 
Assuming that blood flow is steady and that the vessel is a rigid cylindrical tube, vascular resistance (R) is 
proportional to the viscosity of the blood (η) and the length of vessel (L), and inversely proportional to the 
fourth power of the radius of the vessel (r). The relationship of these factors to vascular resistance is 







=  (1.2) 
Since vascular resistance is inversely proportional to the fourth power of the radius, it is clear from this 
equation that vessel diameter has the greatest influence of all the factors combined. As such, change in 
vessel diameter plays an important role in the regulation of blood flow. The factors mediating 
vasoconstriction and vasodilation will be discussed in later sections. 
 
1.2.3 Poiseuille’s Law of Laminar Blood Flow 
Laminar flow (or streamline, non-turbulent flow) occurs when fluid flows in parallel layers in a 
concentric arrangement within a cylindrical tube, without disruption between the layers. During laminar 
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flow, a parabolic velocity profile is formed since fluid molecules adhering to the vascular endothelium in 
the outermost lamina move the slowest, while adjacent layers move with increasing velocity towards to 
the centre (Figure 1-1 ). Poiseuille’s law integrates the velocities of all the concentric rings of the velocity 













Figure 1-1. Poiseuille’s Laminar Flow.  
Concentric layers of fluid (blood) flow through this segment of blood vessel. The black arrows represent 






There are some limitations to the application of Poiseuille’s law in vivo due to several potentially flawed 
assumptions. Contrary to the assumption of Poiseuille’s model, blood is a non-Newtonian fluid since 
viscosity can be altered by hematocrit, fibrinogen level, erythrocyte flexibility, and temperature 24;25 . 
Furthermore, blood vessels are elastic, such that an increased arterial pressure increase not only increases 
the perfusion pressure, but also distends the vessel and changes vascular resistance 26. However, it is still 
generally accepted as an adequate approximation of blood flow in vivo. Poiseuille’s law generally applies 
in relatively straight segments of the blood vessel, although turbulent flow occurs in curved segments, 
where there is branching, or in large blood vessels (eg. the aorta).  
 
1.2.4 Retinal Blood Flow 
As discussed in section 1.2.1, blood flow through a vessel is dependent on a pressure gradient and 
resistance to flow. The pressure gradient, or perfusion pressure, is defined as the difference between local 
arterial pressure (Pa) and local venous pressure. Venous pressure is assumed to be equal to intraocular 
pressure (IOP) for retinal blood flow 27. Blood flow in the retinal vessels is consistent with Poiseuille’s 
law of laminar flow 28.  
 
Intraocular Pressure 
Intraocular pressure (IOP) is the tissue pressure of the ocular contents. This pressure generated by the 
forces exerted by the aqueous produced at the ciliary processes, which flows through the posterior 
chamber and into the anterior chamber, and drains through the Canal of Schlemm and the episcleral veins. 
Clinically, IOP can be measured using applanation tonometry. The normal range for IOP is 10-22 mmHg, 





Blood pressure is a result of the force exerted by blood as it pumped by the heart throughout the 
vasculature. In the systemic circulation, blood pressure normally ranges between 120 mmHg during 
systole and 80 mmHg during diastole. Clinically, blood pressure can be measured using a 
sphygmomanometer.   
 
Mean arterial pressure (MAP) is the average blood pressure over a single cardiac cycle. It is considered 
the perfusion pressure of the vascular beds throughout the body. When diastolic pressure (DP) and 






+=  (1.4) 
 
Ocular Perfusion Pressure 
Ocular perfusion pressure (OPP) is the pressure of blood in the ocular tissues, which sets up the gradient 
for flow. Ocular perfusion pressure is related to mean arterial pressure (MAP) and intraocular pressure 





Conditions that increase OPP beyond the limits of autoregulatory capacity of the retinal vessels have the 
effect of increasing blood flow to the retina. Exercise-induced increase in MAP and decreased IOP result 
in an increased rate of blood flow in the choroid as a result of increase in OPP9;10 and less efficient 
autoregulation of the choroid, whereas no such change in blood flow occurs within the inner retinal 
circulation . Ocular perfusion pressure also varies diurnally, with postural changes, and increases with 
age29;30. Regulation of blood flow in the face of changes in OPP due to postural change demonstrates 
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pressure autoregulation, which will be further discussed in section 1.3.1. Dysregulation of this response is 
associated with the pathogenesis of glaucoma31 and diabetic retinopathy18;19. 
 
1.3  Regulation of Retinal Blood Flow 
Blood flow to the retina is determined by the perfusion pressure and the diameter of the resistance vessels 
(arterioles). Unlike the choroidal and retrobulbar circulation which display autonomic nervous system 
control, the retinal vasculature lacks sympathetic fibres13, and as such there is no nervous system control 
contribution to retinal vascular resistance. The retinal and optic nerve head vessels have α-adrenergic, β-
adrenergic, and cholinergic receptors, but the role of these is unclear32. Local metabolic and myogenic 
stimuli, vascular endothelium-derived substances, and oxygen and carbon dioxide tension are major 
modifiers in vessel diameter, which is a major determinant of blood flow to the tissue since retinal 
arterioles lack precapillary sphincters, which play a role in regulating blood flow in other capillary beds13.   
 
Autoregulation in the retinal vasculature ensures that adequate perfusion of tissue in the face of changing 
nutrient requirements proportional to metabolic activity and alterations in perfusion pressure. 
Autoregulation normally refers to the maintenance of constant blood flow in the face of changes in OPP. 
Metabolic autoregulation refers to change in blood flow as a result of changing nutrient supply, including 
O2 and CO2. Various types of autoregulation and the factors mediating this response in the retina will be 
reviewed in the following sections. 
 
1.3.1 Pressure Autoregulation 
Pressure autoregulation is defined as the ability of the tissue to maintain relatively constant blood flow in 
the face of changes in perfusion pressure. This type of autoregulation only occurs within certain limits. In 
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the human retina, the upper limit for IOP for autoregulation is approximately 50 mmHg (corresponding to 
a mean retinal perfusion pressure of 10 mmHg), although it is only fully effective if mean retinal 
perfusion pressure is reduced by less than 50% (ie. IOP does not surpass 27-30 mmHg)33. A minimum 
IOP of 6 to 7 mmHg is also required34. Increments in brachial MAP, a measure of systemic blood 
pressure, correspond to change in ophthalmic artery pressure. As systemic blood pressure rises above 
approximately 40% from baseline values (ie. brachial MAP is 115 mmHg), the human retina fails to 
regulate flow against changes in retinal perfusion pressure35. Pressure autoregulation in response to 
change in systemic MAP has been studied under conditions of exercise35-37, postural change31, and 
systemic hypertension38.  
 
1.3.2 Myogenic Mechanism 
Transmural pressure is the pressure difference between the lumen and the outside of a blood vessel, in 
contrast to perfusion pressure, which is the pressure difference between two different points within a 
vessel. The myogenic mechanism of autoregulation is related to the Bayliss Effect, which describes the 
contractile reaction of smooth muscle cells in arteriole walls due to an increase in transmural pressure37. 
Perfusion pressure varies during the cardiac cycle and is sustained by changes in MAP; this changes 
intraluminal pressure as blood flows through. When increased intraluminal pressure induces stretching in 
the lumen of the vessel, voltage-gated calcium channels are involved in the reactive constriction of the 
smooth muscle cells in retinal arterioles39. Endothelial cells lay at the interface between blood and the 
smooth muscle layer the blood vessels. Shear stress is the force acting tangentially on the endothelial cells 
in the direction of blood flow. The microvilli located on the apical surface of endothelial cells detects the 
hydrodynamic force exerted by shear stress and causes rearrangement the actin filaments in the 
cytoskeleton to and deformation of the cells40. This triggers the release of nitric oxide (NO), a potent 
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vasodilator26;41. The lack of sympathetic innervation of retinal vessels makes the intrinsic contractility of 
vascular smooth muscle cells an important factor in the regulation of retinal blood flow. 
 
1.3.3 Metabolic Autoregulation/Vascular Reactivity 
Metabolic autoregulation is the ability of a tissue to alter perfusion pressure to match tissue O2, CO2 and 
nutrient needs42.  Metabolism in the neural retina is largely affected by light stimulation. Flickering light 
enhances glucose consumption; however, constant light reduces metabolism while the onset of light 
causes a spurt in metabolism43.  Flicker stimulation increases blood flow to the optic nerve head and the 
retina44;45  to support increased nutrient requirements, particularly in the perifoveolar region where 
ganglion cells and nerve fibres are concentrated46. Flicker-induced hyperemia is a result of vasodilation of 
retinal arteries45;47 due to enhanced NO production under these conditions48. In contrast, choroidal blood 
flow is unaffected by flicker stimulation49 despite the hypothesis that oxygen from the choroid is required 
to support the metabolic activity of the retina50. However, a blue flicker stimulus elicits an increase in 
subfoveal choroidal blood flow, perhaps in response to stimulation of colour-sensitive cones in the 
fovea51. This evidence suggests that metabolic autoregulation in the retina and choroid depends on 
regional sensitivity to stimulation at different wavelengths of light due to the distribution of rods and 
cones. 
 
The high metabolic activity in the neural retina necessitates a steady supply of oxygen since aerobic 
cellular respiration releases more energy from glucose, than anaerobic glycolysis. In the presence of a 
flicker stimulus, there is an increase in retinal arteriovenous pO2 difference since arterial and capillary 
pO2 increases while no change in venous pO2 is observed, indicating the increased oxygen extraction52. 
However, in agreement with the finding that flicker stimulus does not affect choroidal blood flow49, the 




Systemic changes in pO2 and pCO2 also require autoregulation at the level of the retina. Systemic 
hyperoxia (increased arterial pO2) elicits retinal vasoconstriction53 resulting in a decrease in blood flow to 
the retina54-56. An intact vascular endothelium is essential for this response since it is mediated by a potent 
vasoconstrictor, endothelin-1 (ET-1)57;58. When arterial pO2 is increased, O2 is delivered from the choroid 
to the deep retinal capillaries, and almost the whole thickness of the retina can be adequately supplied by 
the choroid alone59. Hypoxia (decreased pO2) stimulates the release of another endothelium-derived 
factor, nitric oxide (NO), which causes vasodilation in the retinal vessels to increase capillary 
perfusion60;61 while also enhancing the uptake of oxygen in local tissues62. Regulation of pO2 in the retina 
is important to avoid ischemia if underperfused, or in the opposite situation, to avoid the potentially 
damaging effects of reactive oxygen species in hyperoxia63. Oxidative stress is linked to the pathogenesis 
of age-related macular degeneration64, and retinopathy of prematurity65. 
 
Carbon dioxide causes vasodilation and an increase in blood flow in the retinal66 and choroidal 
circulations67;68.  The retina is very sensitive to changes in systemic pCO2: a 1% rise in arterial pCO2 can 
induce a 3% rise in blood flow. Although changes in arterial pCO2 and pH of the interstitial retina are 
closely related, acidification of blood by lactate injection does not affect interstitial pH or retinal blood 
flow. Furthermore, systemic hypoxia induces an increase in retinal lactate release, which potentially 
affects vascular tone, as demonstrated by pre-retinal microinjections of lactate.  Together, this suggests 
that interstitial – rather than systemic –  acidosis is a requirement for a retinal vasomotor response to 
hypoxia3. Lactate is produced both aerobically and anaerobically with glucose consumption in the 
retina69. Oxidation of glucose into CO2 in the retina thus affects vasomotor tone in the retinal vasculature. 
Carbogen studies further demonstrate the impact of pCO2 on retinal metabolic autoregulation. When 
carbogen (a gas mixture of 95% O2 and 5% CO2) is inspired, it is thought to relatively improve retinal 
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oxygenation since it results in a less pronounced vasoconstriction than when 100% oxygen is delivered, 
allowing blood through the retinal vasculature at a higher rate70. Although inspiring 100% O2 enhances 
oxygenation of the retina in the treatment of central retinal artery occlusion, co-administration of CO2 
would prevent ischemia due to decreased perfusion pressure. 
 
The purest definition of “autoregulation” implies change in transmural pressure. However, transmural 
pressure is not a factor in the initiation of “metabolic autoregulation”. For this reason, many authors use 
the term “vascular reactivity” rather than metabolic autoregulation. The term vascular reactivity will be 
utilized in this thesis from this point forward. 
 
1.3.4 Endothelium-Derived Factors Affecting Vascular Tone 
Nitric oxide (NO) is synthesized by three distinct isoforms of the enzyme nitric oxide synthase, but the 
isoform that is pertinent to vascular tone is endothelial nitric oxide synthase (eNOS). Endothelial cell-
derived NO diffuses into smooth muscle cells and pericytes causing a change of biochemical events 
leading to vasodilation1. Due to the very short half-life of NO71, production is controlled at the level of 
biosynthesis41. eNOS catalyzes the oxidation of L-arginine, which is then further oxidized to become NO, 
a potent vasodilator that is found systemically but also plays a crucial role in regulating ocular blood 
flow41. NO is continuously produced in the choroid, optic nerve head vessels, and retinal vessels and 
contributes to basal retinal vascular tone 72. Flicker stimuli-induced vasodilation is mediated by NO48;72;73, 
which is consistent with the observation that blood flow at the optic nerve head is proportional to 
neuronal activity 74;75. This ensures adequate blood supply to support increased metabolic activity. Nitric 
oxide is also directly stimulated by, and in some cases important, in the vasomotor responses elicited by 




Endothelins (ET-1, ET-2, and ET-3) are another family of endothelium-derived vasoactive peptides 
(consisting of 21 amino acids each) that bind to adjacent pericytes and smooth muscle cells. They are 
currently the most potent known vasoconstrictor agents and their actions are mediated by three receptor 
subtypes (ETR-A, ETR-B, and ETR-C)1. Different isopeptides and receptors are located in a different set 
of organ systems, and function differently. Of the endothelin isopeptides, ET-1 is the one that is involved 
in modulating vasomotor tone via ETR-A76. Hyperoxia-induced vasoconstriction in the retina has been 
shown to be dependent on ET-157;58. However, endothelins are also known to promote the release of 
vasodilators, prostacyclin and NO, making their net effect on a vascular bed difficult to predict3. The 
significance of this is unclear, although it could presumably be part of a feedback loop that maintains 
vascular tonus at the appropriate level. 
 
1.4 The Measurement of Retinal Hemodynamics 
The eye retinal vasculature is unique from other vascular beds in the body in that it can be viewed non-
invasively. Many techniques have been developed to measure ocular blood flow in the retinal macro- and 
micro-circulations, choroid, and retrobulbar arteries to provide a concerted view of hemodynamics in 
different parts of the eye.  Blood flow is classically described in millimeters per minute per gram of tissue 
which gives the most complete information about blood flow to metabolically active tissue. However, the 
currently available technologies do not report blood flow in these units. In some cases they are even 
reported in arbitrary units.  As such, direct comparison of the results obtained using different procedures 
cannot be made. To date, the Canon Laser Blood Flowmeter is the only instrument that can assess retinal 
blood flow in absolute units. Nonetheless, each approach provides insight into how blood flow is affected 
by different stimuli and in healthy and diseased eyes. This section will describe some the techniques of 




1.4.1 Pulsatile Ocular Blood Flow 
The measurement of pulsatile ocular blood flow (POBF) is based on the relationship between the 
observable pulsatile change in IOP during the cardiac cycle and the resulting change in the ocular volume. 
It is based on the principle that intraocular pressure increases as blood volume in the eye increases during 
systole1. POBF can be assessed using pneumotonometry or interferometry. 
 
1.4.2 Pneumotonometry 
The POBF instrument is a pneumotonometer that measures real-time IOP, recording changes in IOP 
during the cardiac cycle which exhibits a rhythmic sinusoidal pattern with a range of up to 2 mmHg77. 
The recorded IOP wave is converted into an ocular volume based on a presumed universal relationship 
but does not account for reflux and constant outflow1;77. Until recently, it was unclear which ocular 
vascular beds were being observed in POBF measurements. Zion et. al. combined this technique with 
colour Doppler imaging (1.4.9) and demonstrated that POBF was associated with the systolic and 
pulsatile components of blood velocity in both the temporal short posterior ciliary artery and the central 
retinal artery78. This result indicates that POBF have both choroidal and retinal components78;79.   
 
The measurement of POBF is considered an indirect hemodynamic indicator, since only IOP is measured. 
One of the major disadvantages of this technique is that the true volume of the blood bolus entering the 
eye during systole is unknown, since venous outflow and reflux are unknown 77. Furthermore the use of 





1.4.3 Laser Interferometry 
Interferometry directly measures fundus pulsation relative to the cornea, but like pneumotonometry, 
remains an indirect measure of blood flow. Due to the relative strength of the sclera, when the choroid 
engorges with blood during systole, the fundus moves anteriorly towards the cornea, decreasing the 
distance separating them (optical length) 35;77. A single laser beam passes through the eye and is partially 
reflected back by the cornea and the fundus. The interference pattern formed by the light reflected from 
these two sources changes in its geometry as the distance between the retina and the cornea varies with 
the cardiac cycle. The magnitude of the fundus pulsation can be calculated from the change in the 
interference pattern, which is measured by a linear array detector that quantifies the light level along its 
axis1. In the measurement of POBF, interferometry can measure fundus movement in micrometers 
although actual POBF is still unitless1. Laser interferometric measurements of POBF and pulse amplitude 
correlate well with measurements taken with a pneumotonometer and are considered a valid index of 
pulsatile choroidal perfusion in humans79;81;82. 
 
1.4.4 Fluorescein Angiography with Confocal Laser Ophthalmoscopy 
Quantification of retinal blood flow using fluorescein angiography is based on the measurement of the 
amount of time it takes for fluorescein injected into a peripheral vein to appear and travel through the 
retinal vasculature.  This technique yields several parameters including mean circulation time (MCT), 
arteriovenous passage (AVP) time, and mean dye velocity (MDV). The measurement of these parameters 
involves the use of dye dilution curves. The MDV is the time delay between dye arrival at two points in a 
vessel. The MCT (also referred to as mean transit time) is the average time that a fluorescein molecule 
spends in the retinal vascular bed. The AVP, which is used as an alternative for measuring MCT is 




Angiographs of the fluorescein moving through the retinal vasculature was originally recorded as a series 
of photographs. Dye dilution curves were plotted based on the known concentration of the dye and the 
density (fluorescence intensity) as assessed from the photographs. This technique was limited by the 
frequency with which the photographs could be taken. Since the introduction of photographic quantitative 
angiography84, recording of angiographs has been improved with the use of fluorophotometry85, and 
fundus video cameras which provided a motion picture to increase enhanced the temporal resolution 
(sampling rate)83.  
 
Scanning laser ophthalmoscopy is the most current adaptation of this procedure. The Heidelberg retinal 
angiography (HRA) system has as a digital imaging device equipped with argon and near infrared lasers. 
The Rodenstock scanning laser ophthalmoscope (SLO), another imaging device, is equipped with argon, 
infrared, and helium-neon lasers. Both systems have a confocal optical system, whereby laser light 
reflected from the point interest in the fundus is focused through a confocal aperture and quantified by a 
photodetector after scattered light from adjacent sources are blocked by the confocal filter1. The current 
use of scanning laser ophthalmoscopes for fluorescence angiography provides spatial and temporal 
resolution that is superior to previous techniques83. This method is capable of measuring vessel diameter 
and is also sensitive to small temporal changes in retinal hemodynamics as well as regional differences in 
retinal blood flow. It remains, however, a relatively invasive technique of measuring retinal 
hemodynamics1. 
 
1.4.5  Laser Doppler Velocimetry 
The Doppler effect is the change in frequency and wavelength of a wave as perceived by the observer that 
is moving relative to the source of the wave. This phenomenon is exploited by laser Doppler devices to 
measure the velocity of erythrocytes passing traveling through a blood vessel. A laser emitting light at a 
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known frequency (f) is directed at a blood vessel. The frequency of light scattered by a stationary source 
(ie. the vessel wall) is unaffected (f) while the frequency of light scattered a moving source (ie. the 
erythrocytes) is Doppler shifted (f”) (Figure 1-2). The frequency of the shifted light is determined by the 
beat frequency (f’-f) caused by interference between shifted and non-shifted light. 
Erythrocytes 
 Incident Light (f) 
 
Light reflected by 
stationary vessel wall (f) 














Figure 1-2.  Doppler Effect in Blood Vessels.   
The frequency laser light is Doppler-shifted if it is scattered by moving erythrocytes, but remain 
unaffected if scattered by surrounding tissue that is stationary. 
 
The Doppler-shifted frequency of the light scattered by erythrocytes is proportional to the velocity of 
movement. The Doppler shift frequency spectrum (DSFS) recorded from blood column exhibits a cutoff 
frequency which is directly related to the maximum velocity86. The maximum velocity (vmax) is calculated 
from Doppler-shifted frequency (fmax) arising from the light scattered by the fastest-moving erythrocytes, 
while estimating the effects of the intraocular scattering geometry87. This relationship, where λ is the 
wavelength of the incident laser light, n is the index of the flowing medium, θi is the intraocular angle 
between the incident light and the velocity vector, and θs is the intraocular angle between the scattered 













=  (1.6) 
 
Where Poiseuille’s flow applies, the determination of maximum velocity or (vmax) – which corresponds to 
the centre of the blood column – is sufficient for calculating the volumetric flow rate (F). F is related to 
vmax by the following equation, where s is the cross-sectional area of the vessel at the measurement site86. 
  svF max2
1
=  (1.7)  
  
1.4.6 Bidirectional Laser Velocimetry 
By using a system of two photodetectors separated by a known angle, the absolute measurement of the 
speed of erythrocytes flowing through the retinal vessels was possible87. In bidirectional laser Doppler 
velocimetry, scattered laser light is measured in two directions characterized by wave vectors K1 and K2, 
while the direction of the incident laser is kept constant (Figure 1-3). The frequency shift is defined as the 
difference between the maximum frequencies associated with the wave vectors, since the frequency is 
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where f1max and f2max are the cutoff frequencies associated with K1 and K2 respectively. The angles α1 and 
α2 are the angles separating the K1 and K2 vectors from the velocity vector, v. 
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where λ is the wavelength of the incident laser beam, n is the index of refraction of the flowing medium, 
Δα is the angle between K1 and K2, and β is the angle between the velocity vector (vmax) and its projection 
on the plane defined by K1 and K288. The use of two parallel photomultiplier tubes allows the unit to 
deduce the orientation of the blood vessel, and hence the direction of blood flow. This is important since 
the magnitude of the Doppler shift is dependent on the angle between the source (ie. the velocity vector) 
and the observer (the photomultiplier tubes)1. 
 
As an improvement from its precursor instruments, measurements made the bidirectional laser Doppler 
velocimeter are independent from ocular refraction. Furthermore, target fixation is done with the eye 
under examination rather than the fellow eye as in previous instruments, resulting in better stabilization of 
















Figure 1-3. Bidirectional Laser Doppler Velocimetry.  
vmax is the velocity vector of red blood cell, f is frequency of incident laser beam, f1max and f2max are the 
cutoff frequencies associated with the reflected beams K1 and K2 respectively, α1 and α2 are the angles 
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separating K1 and K2 from vmax, Δα is the angle that subtends K1 and K2, and β is the angle between vmax 
and its projection on the plane defined by K1 and K2. (Diagram courtesy of C. Hudson) 
 
1.4.7 Canon Laser Blood Flowmeter 
To date, the Canon Laser Blood Flowmeter (CLBF) is the only retinal hemodynamic assessment device 
that can non-invasively measure volumetric blood flow in absolute units (µL/min)1;77. It is a fundus 
camera-based instrument that uses bidirectional laser Doppler velocimetry to measure blood flow in the 
retinal arterioles and venules. The system uses two lasers that permit the simultaneous quantification of 
vessel diameter and the velocity of erythrocytes passing through, which could not be accomplished using 
previous bidirectional laser Doppler velocimeters. The frequency of a 675 nm laser is shifted by moving 
blood cells and used to determine maximum velocity, while a 544 nm laser is used to measure the 
diameter of the vessel. A computer-automated tracking device is used to stabilize the lasers on the target 
to compensate for eye movements during data acquisition83.  
 
Due to variations in blood velocity observed in arterials during the cardiac cycle, a time-averaged value of 
vmax determined from the DSFS, maxv . Since fluctuations of this nature do not occur in the venous system, 
maxv is assumed to be the same as vmax.  The flow rate, F, is calculated from maxv  and the cross sectional 
area of the vessel, s, such that 




The factor of 2 for the calculation of flow arises from the assumption of Poiseuille’s flow. The quantity, s, 
is calculated from the measured diameter of the blood vessel on the assumption that the cross section is 
circular28. The CLBF has been shown to give consistent and repeatable results89;90. Light scatter has been 
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observed to affect densitometry assessment of vessel diameter, and as such, the CLBF may be of limited 
usefulness when used on patients with cataracts91.  
 
1.4.8 Scanning Laser Doppler Flowmetry 
The Heidelberg Retina Flowmeter (HRF) is the only commercially available scanning laser Doppler 
flowmetry device. As the name implies, this device uses scanning laser technology to measure volumetric 
blood flow in the juxtapapillary region of the retina and the optic nerve head 92. The optical system is 
confocal so it is useful for assessing planar depth1. The laser scans a 2560 × 2560 μm area of the retina or 
optic nerve head with a 785 nm laser diode. The HRF software performs a fast Fourier transform to 
extract the individual frequency components of the reflected light to generate a power spectrum, from 
which a value proportional to the total number of red blood cells times their velocity is determined. The 
results are displayed as perfusion maps with different where colours decode the amount of perfusion, and 
the parameters volume, velocity, and flow are reported in arbitrary units83.  
 
1.4.9 Colour Doppler Imaging 
Colour Doppler imaging is another retinal hemodynamic assessment technique that uses the Doppler 
effect. However, while the instruments that have already been described here relate the shifted frequency 
of light, this technique measures the Doppler-shifted frequencies of ultrasound waves to assess the blood 
flow in low velocity vessels (ie. the central retinal artery and posterior ciliary artery) and high velocity 
vessels (ie. the ophthalmic artery), depending upon adjustable sensitivity and depth settings. A coloured 
representation of a B-scan ultrasound image allows visualization of blood flowing through the orbital 
vessels77. Peak systolic and end-diastolic velocities are identified and used to calculate the resistive index 
associated with the vascular beds perfused by the artery being measured. Colour Doppler imaging has the 
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advantage of being non-invasive (performed on a closed eye), and is effective in eyes with poor optical 
media1. A potential problem arises with this procedure if too much pressure is applied with the transducer, 
as this could cause a temporary rise in IOP which could have a confounding effect on ocular 
hemodynamics. 
 
1.5 Studies in Retinal Blood Flow During Hyperoxia 
It has been demonstrated in many studies that blood flow varies depending on systemic arterial oxygen 
tension53;55;70;93-97;97-102. When systemic hyperoxia is initiated by manipulating inspired gases, local 
increases in O2 tension elicit the vascular reactivity response in the retinal arterioles, causing 
vasoconstriction to reduce blood flow in order to maintain a steady supply of O2 to the retina42. The  
vascular reactivity limits of the retinal vasculature were investigated by maximizing systemic hyperoxia 
(pure O2 breathing) in most studies53;70;93-101, however, only a few studies demonstrated the effects of 
varying the pO2 of the inhaled gas98;100. Several problems are inherent in these studies including the lack 
of standardization of hyperoxia. Without measuring arterial pO2 or at least a surrogate indicator, it is 
impossible to determine whether the breathing stimulus exerted an equal vasoconstrictive influence in 
each subject since systemic pO2 can vary between individuals given the same gas stimulus. In addition, 
these studies failed to control against changes in pCO253;70;93-96;98-101. Given the vasodilatory effect of CO2 
on the retinal vasculature, changes in pCO2 confounded the results66;96. Isocapnia was maintained in only 
a few studies in which hyperoxia was the primary stimulus55;97;102. This can be achieved using a sequential 
re-breathing circuit in which fresh gas was enriched with CO2 from rebreathed gas to prevent hyperoxia-
induced hypocapnia102 or by supplementing pure O2 with CO297. In addition to better control of the 
stimulus, this method improved hemodynamic measurements by reducing variability in the data 102. One 
study has reported a linear relationship between systemic pO2 and retinal hemodynamics98, however, in 
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studies that only compared pure O2 versus air breathing, a curvilinear relationship could not be excluded 
53;70;93-101.  
 
There is consensus among the studies that hyperoxia produces a profound reduction in retinal blood 
flow53;55;70;93-97;97-102. The rate of blood flow during hyperoxia relative to normoxia can be assessed, 
however, the methods of ocular hemodynamic measurements (1.4) each have unique limitations including 
simplifications or assumptions of ocular blood flow characteristics, or the inability to measure blood flow 
in absolute units which prevent the assessment of retinal blood flow for each of the different conditions in 
absolute terms1;77;103. Each hemodynamic measuring device assesses a different part of the ocular 
circulation98. Vascular reactivity varies with regional differences within the retina97, further complicating 
such comparisons. These data should therefore be interpreted with an adequate understanding of the 
techniques that are used and the anatomy and physiology of ocular blood flow 
 
1.6  Summary 
As the retina is the only location within the body where internal blood vessels can be viewed directly and 
non-invasively, it presents as a unique opportunity for the study of hemodynamics. The anatomy and 
physiology of ocular blood flow, with particular attention to blood flow in the retina has been reviewed 
here. The retina is the most metabolically active tissue in the body while also being particularly 
vulnerable to periods of low perfusion due to the peculiarities of its anatomy, physiology, and function. 
As such, proper control of blood flow to the retina to ensure adequate delivery of nutrients, removal of 
wastes, and oxygenation are essential to maintaining the health of the eye. 
 
To this end, many techniques have been developed to assess in vivo ocular hemodynamics for clinical and 
experimental purposes. This is by no means an exhaustive review of the devices and techniques that have 
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been devised to assess ocular hemodynamics. It is, however, a sample of some of the techniques that have 
been used to study the blood vessels and capillary beds of the retina, the choroid, and the optic nerve 
head. These have been used to measure baseline hemodynamics along with various stimuli such as 
flickering light and inspired gases to assess the reactivity of the vessels in both health and disease. A 
decline in the ability of the vasculature to regulate perfusion in the face of these stimuli are part of the 
pathogenesis or sequelae of various eye disease such as diabetic retinopathy, age-related macular 
degeneration, and glaucoma. Each of the techniques provide a view of what is happening in different 
vascular beds, however, since blood flow is measured in arbitrary units in most cases, it is difficult to 
relate the findings between the various studies that have been published. Nonetheless, assessment of 
ocular hemodynamics in its various forms contributes to our understanding of the basic physiology of the 




Rationale for Investigating Retinal Vascular Reactivity in Isocapnic 
Hyperoxic Conditions  
The retinal arterioles are resistance vessels that control the rate of blood flow by altering lumen diameter. 
A reduction in diameter will reduce blood flow, while an increase in diameter will increase blood flow. In 
the inner retina, diameter is modified through the influence of the myogenic response, endothelium-
derived factors, local hormones, and tissue metabolites in the absence of sympathetic innervation. These 
mechanisms ensure a steady supply of oxygen to the retina to support its high metabolic needs. Vascular 
reactivity or metabolic autoregulation is the ability of a tissue to alter perfusion to match the O2, CO2, and 
nutrient needs42 of the retina and is a quality exhibited by the major retinal arterioles.  
 
Vasoconstriction and reduction in retinal blood flow in response to hyperoxia induced by increased 
inspired oxygen levels has been demonstrated in many studies53;70;93-101.  Hyperoxia was induced by 
breathing 100% oxygen in these studies, without controlling for changes in CO2 tension in the arterial 
blood53;70;93-96;98-101. Hemoglobin is nearly saturated in normoxic conditions in a healthy person, and 
breathing pure oxygen almost exclusively increases pO2 in arterial blood by increasing the amount of O2 
dissolved in the plasma. Since oxyhemoglobin binds less CO2 (Haldane effect)104-106, what results is a 
reduction of pCO2 in the arterial blood, an accumulation of CO2 and bicarbonate in local tissue, which 
stimulate central chemoreceptors to cause hyperventilation63;107;108. Hyperventilation further exacerbates 
hypocapnia. The magnitude of the hypocapnic effect elicited during hyperoxic provocation varies 
substantially from one individual to the next. Since CO2 causes vasodilation of responsive resistance 
vessels including retinal arterioles66, a decrease in CO2 during hyperoxic provocation would exaggerate 
the vasoconstrictive effect and confound the influence of hyperoxia on vascular reactivity. Co-
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administration of CO2 with hyperbaric O2 elicits a smaller vasoconstrictive effect than pure O2 breathing 
70;96;109, demonstrating this hypocapnic effect. The compounded vasoconstrictive effect makes data from 
previous studies difficult to interpret, emphasizing the importance of maintaining isocapnia during 
hyperoxic experiments so that the effect of O2 breathing can be isolated from CO2 drift. 
 
A sequential rebreathing circuit was developed to standardize O2 provocation defined by fractional-
expired O2 (FeO2) delivery, while also preventing the reduction of end-tidal CO2 (ETCO2). This is 
achieved using two gas reservoirs interconnected by a single positive end expiratory pressure (PEEP) 
valve, which allows for rebreathed gas from one of the reservoirs to mix with gas from the fresh gas 
reservoir. The flow rate of fresh gas is adjusted such that ETCO2 is maintained at the subject’s 
homeostatic level when breathing through the mask. The mixing of fresh and rebreathed gases ensures 
that the subject breathes enough CO2 to prevent hypocapnia. Regulation of end-tidal concentrations of O2 
and CO2 in this way reduced the variability of retinal hemodynamic measurements compared to other 
methods of gas delivery102. This technique is manually-operated and must be continuously monitored by 
the experimenter for possible ETCO2 drifts, and fresh gas flow is adjusted accordingly. Normoxia and 
hyperoxia are stimulated using air and 100% O2 gas, respectively, and different incremental increases of 
O2 between normoxia and hyperoxia (defined in this method as 100% O2) could not be achieved without 
utilizing a special gas mix. 
 
A recently developed computer-controlled gas delivery system can compensate for some of the 
limitations of the manually-operated system. An almost identical sequential rebreathing circuit was used, 
however, the O2 and CO2 demand to match a user-input PetCO2 and PetO2 is automatically calculated by 
the delivery system, and is adjusted on a breath-by-breath basis to stabilize the levels of O2 and CO2 in the 
systemic circulation. Three source gases with different proportions of O2, CO2, and N2 are mixed together 
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to achieve the user-input targets while also ensuring that a safe minimum of N2 and O2, or safe maximum 
of CO2 are delivered to the participant. Through better control of both pO2 and pCO2, the computer-
controlled gas sequencer permits sequential changes in PetCO2 and PetO2 and is thought to produce more 
reliable results when measuring retinal vascular reactivity. It is also capable of faster transitions between 
gas challenges allowing systemic blood gas to equilibrate more quickly and accurately than with the 
previous method. 
 
Due to the benefits of the computer-controlled gas delivery system, it is likely to replace the manually-
operated system in retinal vascular reactivity studies in our lab. However, since previous studies 
investigating the retinal vascular response to hyperoxia were conducted with the manually-operated 
system, it was important to compare the performance of both gas delivery systems in terms of retinal 
hemodynamic measurements. This is the rationale for the study described in Chapter 3 of this thesis. One 
measurable difference between the two gas delivery methods is in the delivery of O2 during hyperoxia. 
The manually-operated system can achieve FeO2 levels up to approximately 85%, a level which can vary 
greatly between participants as a result of differences in tidal volume. However, the computer-controlled 
system can only achieve approximately 70% FeO2 while maintaining the comfort and safety of the 
participant but with greater consistency between participants. Retinal arteriolar diameter, blood velocity, 
and blood flow were each assessed to determine how the differences in oxygen delivery between the two 
systems were relevant in the context of the magnitude and variability of retinal vascular reactivity to an 
isocapnic hyperoxic provocation. In short, the aim of Chapter 3 is to compare the retinal hemodynamic 
measurements obtained from two different gas delivery methods to provide insight on how data from both 




Although the maximal FeO2 target is lower for the computer-controlled delivery system, its main 
advantage in hyperoxia studies is in its capability to produce a range of FeO2 increments between 15-
65%. The aim of the study described in Chapter 4 was to investigate the retinal arteriolar response to 
randomised incremental hyperoxic stimuli while maintaining isocapnia. Previous studies have 
investigated the retinal vascular reactivity to the maximum hyperoxic response that can be attained using 
their respective methods18;53;55;70;93-95;97;99;101;102;110 and compared to air breathing i.e. 15% FeO2. 
Alternately, they have provided normal physiological data to demonstrate the nature of the relationship 
between different levels of hyperoxia and retinal vascular reactivity96;98;100, but failed to control for 
hyperoxia-induced hypocapnia53;70;93;94;98;99;101, or even deliberately altered the concentration of CO2 in the 
source gases95;96;100. Furthermore, different levels of hyperoxia were achieved by altering the pO2 in the 
source gas, but this does not account for level of gas exchange. In other words, the magnitudes of FeO2 
and ETCO2 were not standardized in these studies. The primary goal of the study described in Chapter 4 
is to determine the relationship between incremental hyperoxia during isocapnia and vascular reactivity in 
the retinal arterioles using standardized FeO2 increments. To the best of our knowledge, this has not been 
previously achieved. 
 
The overall aim of this thesis is to evaluate different methods of stimulating isocapnic hyperoxia in retinal 
hemodynamic studies and to determine how retinal arterioles react at various levels of hyperoxia while 
ensuring isocapnia. Impairment of vascular reactivity is a hallmark of ocular diseases with vascular 
etiologies, including diabetic retinopathy, age-related macular degeneration and glaucoma. A better 
understanding of the experimental methods and physiological relationships behind hyperoxic provocation 





Comparison of Gas Delivery Systems on the Outcome of Retinal 
Vascular Reactivity Measurements to Isocapnic Hyperoxia 
3.1 Abstract 
 
Purpose: The aim of the study was to compare the magnitude and variability of the retinal vascular 
reactivity response to an isocapnic hyperoxia stimulus delivered using a manually-operated method to that 
of a newly developed computer-controlled gas sequencer.  
 
Methods: The sample comprised 10 young, healthy subjects. During a single visit, subjects inhaled gases 
in a sequence of normoxic baseline, isocapnic hyperoxia, and normoxic recovery, using both gas delivery 
systems in random order. End-tidal partial pressure of carbon dioxide (ETCO2) and fractional expired 
oxygen (FeO2) were continuously monitored. Blood flow was derived from retinal arteriolar diameter and 
simultaneous blood velocity measurements of the superior temporal arteriole, acquired at 1-minute 
intervals during each of the phases of the gas protocol.  
 
Results: There was no interaction effect between the phases and gas delivery methods (p = 0.7718), but 
ETCO2 was significantly reduced during hyperoxia (p = 0.0002) for both methods. The two systems 
differed in terms of FeO2 during hyperoxia, at a level of 85.27 ± 0.29% for the manual method, and 69.02 
± 2.84% for computer method (p < 0.05). Despite this difference in oxygen concentrations, there was no 
difference in the vascular reactivity response for diameter (p = 0.7756), velocity (p = 0.1176), and flow (p 




Conclusions: Inter-subject variability for virtually all retinal hemodynamic parameters was reduced using 
the computer-controlled method, presumably due to a higher degree of gas control. However, due to the 
relatively small sample size care needs to be exercised in the interpretation of this result. A similar retinal 
hemodynamic response to isocapnic hyperoxia was induced using the two gas delivery systems, despite 




Metabolic autoregulation of the retinal arterioles ensures that the oxygen supply attempts to match the 
metabolic activity of the retina in spite of changes in the concentration of inspired gases42. One unique 
feature of the retinal vasculature is that it lacks sympathetic innervation32, and as a result, the influence of 
endothelial-derived factors and local metabolites play an important role in the regulation of vasomotor 
response of the resistance vessels of the retina. Retinal blood flow varies directly with the arterial partial 
pressure of CO2 (PaCO2) and inversely with the arterial partial pressure of O2 (PaO2). Hyperoxia induced 
by O2 breathing causes vasoconstriction in the retinal arterioles, a process which is influenced by 
endothelin-1 (ET-1)57;58.  Impairment of vascular reactivity of retinal blood flow in response to hyperoxia 
has been demonstrated in diabetic retinopathy18;97 and glaucoma111.  
 
Many experiments simply induce hyperoxia through 100% O2 breathing53;70;93-101. This methodology 
presents a number of problems. First, it erroneously assumes that 100% O2 breathing produces the same 
degree of systemic hyperoxia in all participants112, and hence, the degree of provocation of is not 
standardized. Fractional expired oxygen (FeO2) should be monitored as a surrogate measure of the partial 
pressure of O2 (pO2) in the arterial blood and O2 delivery should be adjusted accordingly to reduce 
variability of the O2 across subjects within a study. Second, hyperoxia induces hypocapnia, a condition 
which was not considered in many studies63;102. Oxyhemoglobin has a lower affinity for CO2 binding 
resulting in CO2 and bicarbonate build-up that stimulates brainstem chemoreceptors to increase the 
respiratory rate107;108. Hyperventilation worsens hypocapnia, which results in vasoconstriction at a level 
that is greater than that caused by hyperoxia alone63. In this way, the effect of hyperoxia on autoregulation 




A sequential rebreathing circuit can be used to manipulate inspired and expired gases, such that during 
inspiration, the subject inhales a mixture of fresh gas along with a small amount of gas from a rebreathed 
gas reservoir 102. This system can effectively minimize CO2 drift during hyperoxia induction with pure O2 
breathing because it is supplemented by CO2 from the rebreathed gas reservoir, maintaining normocapnia. 
However, with this method, FeO2 cannot be standardized between study participants since normoxia and 
hyperoxia are induced using one standard air and 100% O2 respectively, and FeO2 equilibrates at different 
levels depending on each person’s gas exchange rate. Changes in FeO2 are controlled manually between 
normoxia and hyperoxia. This system has been used in a number of studies that investigated retinal 
vascular reactivity to isocapnic hyperoxia challenge18;55;102. 
 
A recently developed computer-controlled gas delivery system combined the sequential rebreathing 
circuit with an automated system that can simultaneously standardize FeO2 and ETCO2 across subjects in 
a study. This is accomplished by blending 3 different source gases and breath-by-breath monitoring of 
exhaled gases to adjust the relative concentrations of the source gases to achieve the user-input ETCO2 
and FeO2 target levels, following a programmed time sequence. It was previously found that better 
control of the gas parameters reduced the variability of retinal hemodynamic measurements using a 
manually-operated sequential rebreathing circuit102. The purpose of this study was to compare the 
magnitude and variability of retinal hemodynamic measurements between the manually-operated and 




3.3 Materials and Methods 
3.3.1 Participants 
Ten healthy adults (5 men, 5 women) were enrolled in the study, ranging in age from 21 to 33 years 
(mean age 27.1 years, SD ± 4.43).  All participants had a corrected logMAR (logarithm of the minimum 
angle of resolution) visual acuity of 0.0 or better. Participants were excluded if they had refractive error 
greater than ± 6.00 DS and/or ± 2.50 DC. They were also excluded from the study if they had a history of 
ocular disease or disorder, including lenticular opacity which interfered with imaging measurements91. 
The participants had no history of intraocular or refractive surgery. People with a history of systemic 
disease including respiratory disorders, heart or cardiovascular disease, or hypercholesterolemia were also 
excluded. Systemic medications with known vasoactive effects were also excluded. Since caffeine has 
known transient systemic vasoconstrictive effects in humans, and effects on retinal hemodynamics113, 
subjects were also asked to refrain from caffeine-containing food products such as coffee, tea, chocolate 
for 24 hours prior to their study visit. A diminished reduction of blood flow secondary to hyperoxia has 
been observed in the retinal circulation of smokers, a response attributed to the long-term effects of 
nicotine on the sympathetic and parasympathetic nervous system114. As such, current smokers, or those 
who have smoked cigarettes within six months of the study, were also excluded from participation.  
 
3.3.2 Pre-Data Collection Screening 
Prior to data collection, a screening was performed to ensure that each participant met the study criteria. 
A medical history was taken, with questions pertaining to the aforementioned exclusion criteria. Blood 
pressure and pulse measurements were taken using a digital blood pressure monitor (Omron HEM-907, 




Visual acuity was measured with the Early Treatment of Diabetic Retinopathy Study (ETDRS) logMAR  
charts115. Since participants in the study are expected to have good corrected visual acuity, they were 
asked to start at the row in which they can comfortably read all five letters, and continue to read the letters 
down the chart until they could not correctly identify a minimum of three letters while wearing their 
spectacles. The last line that the participants could read was recorded. These measurements were taken to 
ensure that the participants met the vision requirement so that optical defects did not interfere with CLBF 
imaging. 
 
Prior to blood flow data acquisition, a drop of fluorescein was applied to the cornea to screen the cornea 
and tear film for abrasions or irregularities that could interfere with imaging. Study participants were also 
asked if they had known allergies to the ophthalmic drops used in the study. Van Herrick’s angle 
assessment was performed to determine the risk of anterior angle closure, prior to the use of mydriatic 
drops. Once it was determined that mydriasis was safe (ie. cornea to chamber ratio > 1:1/2), one drop of 
1% Tropicamide was applied to the randomly chosen study eye.  
 
3.3.3 Gas Delivery Systems 
3.3.3.1 General Protocol 
Participants were fitted with a face mask and a gas delivery system comprising a sequential re-breathing 
circuit through which they breathed a controlled mixture of gases (Figure 3-1). A transparent medical film 
dressing (3MTM TegadermTM, St. Paul, MN) was used to secure the mask and to create an airtight seal 






Figure 3-1. Experiment Set-up.  
Participant is fitted with a face mask and rebreathing circuit. To the left of the photo (behind the 
participant) is the computer-controlled gas delivery system with 3 tanks of compressed gases. In the 
background is the manually-operated system with 3 rotometers used to control the flow of gas from two 
compressed tanks (air and 100% O2). To the right (in front of the participant) is the CLBF used for retinal 
hemodynamic measurements. 
 
Manually-operated and computer-controlled sequencer gas delivery systems were used in random order 
during a single study visit. In general, a sequence consisting of a normoxic baseline, hyperoxia, and 
normoxic recovery, whilst maintaining isocapnia throughout, was achieved using both methods. End-tidal 
(end of exhalation) partial pressure of oxygen (PetO2) and carbon dioxide (PetCO2), which is the 
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maximum concentration of each gas during expiration, were sampled since these parameters reflect the 
arterial partial pressure of oxygen (PaO2) and carbon dioxide (PaCO2).  
 
3.3.3.2 Sequential Rebreathing for Isocapnic Hyperoxia 
A sequential rebreathing circuit consisting of a fresh gas reservoir and a rebreathed gas reservoir that are 
interconnected by two one-way valves and a single positive end-expiratory pressure (PEEP) valve 
between them (Hi-Ox80, Viasys Healthcare, Yorba Linda, CA) can be used to maintain a constant level 
of ETCO2. The participant inhales gas from both the fresh gas and re-breathed gas reservoirs with each 
inhalation, and the CO2 in the re-breathed gas essentially maintains isocapnia.  
 
As fresh gas flows from the gas tank, it enters the fresh gas reservoir. Negative pressure from the mask 
produced by inhalation opens the one-way valve connected to the fresh gas reservoir, thus allowing fresh 
gas to enter the mask. Positive pressure from the mask produced by exhalation opens the one-way valve 
connected to the rebreathed gas reservoir, allowing gas to enter that chamber.  
 
Rebreathing occurs when the participant’s ventilation rate exceeds the rate of gas flow from the 
inspiratory limb of the system. In this situation, negative pressure from the mask opens the PEEP valve 
that connects the inspiratory limb with the expiratory limb. This unidirectional valve allows re-breathed 
gas to enter the inspiratory limb, increasing pCO2 of the inspired gas.  
 
The process described here is relevant to both the manually-operated and computer-controlled gas 
regulation systems. There are, however, several distinctions between the two systems in regulation of the 
gas parameters that will be described in the following sections 
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3.3.3.3 Manually-Operated Gas Delivery System 
This system has been previously described102, but due to the relevance of its design in this study, the 
details will be outlined here. The sequential rebreathing circuit for the manually-operated gas delivery 
system consisted of a fresh gas reservoir (750 mL) and re-breathed gas reservoir (2000 mL) as described 
in the previous section. Standard rotometers acted as flowmeters, to regulate the delivery of gas from two 
gas tanks. One tank contained 100% oxygen and the other contained air. Air was delivered to the patient 
during normoxic phases, ie. baseline and recovery, while oxygen was delivered to induce hyperoxia. The 
flow from each of the gas tanks were manually adjusted at the start of each phase until end-tidal carbon 
dioxide (ETCO2) and fractional expired oxygen (FeO2) levels were stabilized. Gas parameters were 
monitored using the Datex Ohmeda CardiocapTM/5, a rapid-response critical care monitor. 
 
The desired flow rate of fresh gas was achieved when partial rebreathing was occurring. This was 
evidenced by the partial collapse of the rebreathed gas reservoir at each breath and verified by the 
respiratory waveform on the critical care monitor. 5% ETCO2 was the target at all phases, while FeO2 
varied from 15% during normoxia to approximately 85-90% during hyperoxia (Figure 3-2). However, 
since the method depends upon minute ventilation, ETCO2 and FeO2 stabilized at individual homeostatic 




































Figure 3-2. Gas Sequence for Manually-Operated Gas Delivery System.  
The gradual transition in FeO2 between phases is a feature of this method of gas delivery, as indicated by 
the red line (O2). Isocapnia is maintained throughout the protocol, as indicated by the flat blue line (CO2). 




3.3.3.4 Computer-Controlled Gas Delivery System 
A similar rebreathing circuit was used for the computer-controlled gas delivery system.  The same mask 
(Hi-Ox80, ViasysHealthcare, Yorba Linda, CA) featuring two gas reservoirs interconnected by a single 
PEEP valve was used. The main difference in the sequential rebreathing circuit was the expansion of gas 
reservoirs. The inspiratory limb consisted of two continuous fresh gas reservoirs (1500 mL combined 
volume) and expiratory limb consisted of two continuous re-breathed gas reservoirs (4000 mL). The 
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potential volume of the fresh gas reservoir was greater than the actual volume of gas it contained, given 
the variable flow rate of gases between participants to achieve end-tidal gas parameters.  
 
The computer-controlled method of regulating end-tidal carbon dioxide and oxygen levels was unique 
from the manually-operated method. Metabolic parameters, consisting of oxygen uptake rate (VO2) and 
carbon dioxide elimination rate (VCO2), were sampled through the built-in gas analyzer prior to the start 
of the experiment. These measurements are related to individual metabolic rate and physiological 
deadspace, the component of ventilation that does not participate in gas exchange. The algorithm 
controlling gas delivery accounts for these parameters when calculating the amount and mix of gas 
required by the individual.  
 
Unlike the manually-operated apparatus, it induces a target PetO2 and PetCO2 of the subject independent 
of each other and independent of minute ventilation. Sequential changes to different target PetO2 and 
PetCO2 are controlled by the Up-Down Program, a software package designed to analyze breath-by-
breath changes in PetO2 and PetCO2 and vary the delivery of gas through the apparatus in order to 
stabilize both parameters during each of the phases. The sequence of normoxia, hyperoxia, and normoxic 
recovery at isocapnia were pre-programmed using the Up-Down Program. The targeted PetCO2 during all 
phases was 38 mmHg, which corresponds to approximately 5% ETCO2, ie. baseline PetCO2 was 
normalized across individuals. The targeted FeO2 level was approximately 14% (100 mmHg PetO2) for 
both baseline and recovery phases, and 70% (500 mmHg PetO2) during hyperoxia (Figure 3-3). 
Sequential changes to target PetO2 and PetCO2 occur with shorter transition times using this method, 
without the need to change minute ventilation on the part of the subject. However, when changes in 
minute ventilation occurred, the delivery of fresh gas was automatically altered to maintain PetO2 and 





1) It calculates, for a given total flow, fractional concentrations of O2 and CO2 entering the 
sequential gas delivery circuit required to attain a target PetO2 and PetCO2. 
2) It identifies and provides the total flow by mixing component flows of source gases. The 
source gases contain a safe minimum concentration of O2, and/or N2, and/or maximum of 
CO2. Specifically, the source gases were 100% oxygen, air, Gas A (10% O2, 90% N2), 
and Gas B (40% CO2, 10% O2, 50% N2). 
3) If changes in target PetO2 and PetCO2 are required, it identifies and applies transient 
changes in the partial pressure of O2 (PO2) and the partial pressure CO2 (PCO2) in the 
total flow that would accelerate the change in the patient’s blood gases towards the new 
target levels. 
 
In this way, the computer-controlled gas sequencer apparatus allowed for full automation. However, if 































































Figure 3-3. Gas Sequence for Computer-Controlled Gas Delivery System.  
Square-wave transitions between phases is possible when this system is used. Isocapnia is maintained 
throughout the protocol, as indicated by the flat blue line (CO2). The red line (O2) reflects changes in 
FeO2 which was targeted at 70% for the Hyperoxia phase and 14% for Baseline and Recovery phases.  
 
3.3.4 Canon Laser Blood Flowmeter (CLBF) 
The CLBF non-invasively measures volumetric retinal blood flow using bidirectional laser-Doppler 
flowmetry 87. This fundus camera-based instrument provides an image of the retina which allows the 
operator to target a specific sampling site on an arteriole or venule. After the pupil is dilated, the 
participant is asked to follow the movement of the fixation target until it is in the correct position for the 
laser. The head of the CLBF is positioned by the operator such that two flashing yellow triangles, the 




Two lasers are activated and measurements are made within a user-specified, 2-second time frame. The 
green rectangular He-Ne laser (543nm, 4-6 μW), oriented perpendicularly to the vessel axis, tracks the 
vessel and measures the vessel diameter. Tracking stabilizes the measurement site during small eye 
movements. Retinal vessel diameter is determined by computer analysis of densitometry vessel profiles 
taken by a linear imaging sensor every 4 milliseconds just before and after each velocity measurement, 
for a total of 15 vessel profiles for each 2-second sampling period. 
 
The red oval laser diode (675 nm, 200-300 μW) light is emitted to measure the centerline velocity (mm/s) 
of erythrocytes. Two photomultiplier tubes separated at a fixed angle simultaneously detect Doppler-
shifted light scattered by moving erythrocytes87. The use of bidirectional photodetectors permits the 
quantification of blood velocity, irrespective of the angle between the moving blood cells and reflected 
light. Computer analysis of the signals from the detectors determines the centerline blood velocity.  
 
A single measurement site was chosen approximately one disc diameter from the optic nerve head in the 
superior retinal arteriole. The CLBF software records the exact location of the measurement site so that it 
is consistent for each participant within and between experiments, allowing for reliable comparisons. 
Measurement sites were located in a relatively straight segment of the vessel that was free from 
bifurcations, since Poiseuille’s (non-turbulent) flow is assumed.  During each of the gas phases, 6 CLBF 
measurements were taken after the end-tidal gases stabilized. A period of at least 10 minutes after 
cessation of the hyperoxic stimulus was allowed before CLBF measurements were taken since a recent 
study in our lab found that vasoconstriction can persist for approximately up to that length of time after 
hyperoxia. This ensured that no residual vasoconstriction due to hyperoxia would influence the CLBF 




3.3.5 Data Analysis 
3.3.5.1 Gas Data 
 
End-tidal gas parameters were recorded directly by either a critical care gas monitor for the manually 
operated system or by an in inherent feature of the computer-controlled gas delivery system, on a breath-
by-breath basis. PetO2 and PetCO2 were reported in mmHg, and were converted to FeO2 and ETCO2, 
which are reported as a percentage of the atmospheric pressure. Upon plotting FeO2 and ETCO2 against 
time (in minutes), values derived during the transition between normoxic and hyperoxic phases were 
excluded. The transition phases were defined as the time interval between the initiation of a new phase by 
varying the concentration of the delivered gas and the time at which both FeO2 and ETCO2 were 
stabilized. The transition was easily identified by the shape of the waveform when the end-tidal gasses 
were plotted against time in a graph, and because the initiation of the stimulus between phases was 
carefully noted during data collection. Data points lying outside the 10th and 90th percentiles (ie. 3 SDs 
from the mean) of each phase were excluded as outliers, since they were likely the result of 
misinterpretation of the tidal waveforms by the gas monitor. 
 
3.3.5.2 CLBF Data 
 
A post-acquisition analysis of the velocity waveforms were performed using a standardized protocol to 
remove aberrant waveforms affected by eye movements, tear film breakup, or improper tracking of the 
measurement laser. Velocity waveforms were accepted if there was a minimum of one complete cardiac 




3.3.5.3 Statistical Analysis 
 
Differences in end-tidal gas parameters (ETCO2 and FeO2) for each phase (baseline, hyperoxia, and 
recovery) was analyzed using repeated measures ANOVA (reANOVA). Similarly differences in retinal 
hemodynamic parameters (blood vessel diameter, blood velocity, and blood flow) were analyzed using 
reANOVA for each phase in the gas sequence. Fishers’s Least Significant Difference (LSD) tests (α = 
0.05) were performed where gas phases were found to have a significant effect on either end-tidal gas or 
retinal hemodynamic parameters. The coefficients of variation (COV), defined as SD divided by the 
mean, were calculated for the stimulus variables (FeO2, ETCO2) and the response variables (arteriolar 
diametery, blood velocity, and blood flow) during each treatment (gas delivery method by phase) to 
compare the variability between each gas delivery method.  
 
3.3.6 Results 
3.3.6.1 End-Tidal Gas Parameters  
Table 3-1 summarizes the means and SDs of the ETCO2 and FeO2 during each phase of the gas protocols 
for each gas delivery method. The manually-controlled and computer-controlled gas delivery systems 
were significantly different for both ETCO2 (p < 0.0001) and FeO2 (p < 0.0001).  
 
There was no interaction effect between the phases and gas delivery methods (p = 0.7718), but the effect 
of phase was found to be significant (p = 0.0002). Post hoc t-tests (LSD) showed that ETCO2 was 
significantly reduced during hyperoxia (p < 0.05) using both gas delivery systems. However, the change 
in ETCO2 was less than 1%. The interaction effect between the phases and gas delivery method was 
significant for FeO2 (p < 0.0001). During normoxia (i.e. baseline and recovery phases), FeO2 values were 
comparable for both gas delivery methods. The interaction effect can be attributed to the hyperoxia phases 
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(p < 0.001) in which 85.27 ± 0.29% FeO2 was achieved using the manually-controlled method, while only 
69.02 ± 2.84% FeO2 was achieved using the computer-controlled method. All other comparisons of 
baseline and recovery FeO2 values between gas delivery methods were not significantly different. 
 
The variability of each gas delivery method, ie. the ability of each method to produce reliable end-tidal 
gas targets between individuals, was evaluated using coefficients of variation (COV), summarized in 
Table 3-2. Generally, the variability of end-tidal gas parameters was similar between the two methods. 
However, since ETCO2 levels could not be normalized using the manually-controlled method, the outliers 
represent individuals who have higher or lower homeostatic ETCO2  levels (Figure 3-4). In contrast, the 
absence of outliers for the ETCO2 using the computer-controlled method demonstrates that this method 
was able to achieve a similar target level for all participants. The coefficients of variation were also 
similar for both methods for FeO2, as shown in Table 3-2. The presence of extreme outliers 
accompanying a smaller range for the computer-controlled method suggests that it is also more capable of 
regulating FeO2, but that approximately 70% FeO2 represents the upper hyperoxic limit using this 
technique (Figure 3-5).  
 
Table 3-1.  Summary of End-Tidal Gas Parameters 
Manually-Operated Computer-Controlled  
Baseline Hyperoxia Recovery Baseline Hyperoxia Recovery 
       
ETCO2 5.02 ± 0.23 4.95 ± 0.21 5.01 ± 0.22 5.55 ± 0.33 5.49 ± 0.29 5.52 ± 0.33 
FeO2 15.05 ± 0.29 85.27 ± 5.61 15.17 ± 0.21 14.61 ± 1.23 69.02 ± 2.84 14.22 ± 0.21 





Table 3-2. Coefficients of Variation for End-Tidal Gas Parameters 
Manually-Operated Computer-Controlled  
Baseline Hyperoxia Recovery Baseline Hyperoxia Recovery 
       
ETCO2 4.7 4.2 4.3 6.0 6.4 6.1 
FeO2 1.9 6.6 1.4 1.7 4.1 1.4 
Values are expressed as %. 
 
 
Figure 3-4. Boxplots of ETCO2 at Each Phase for Both Gas Delivery Systems.  
The non-outlier range (whiskers) is defined as 1.5H below the 25th percentile or above the 75th percentile, 
where H is the height of the box or the interquartile range. Outliers are denoted by open circles (○). 
Extreme outliers are denoted by asterisks (*), indicating that the values fall 3H below the 25th percentile 




Figure 3-5.  Boxplots of FeO2 at Each Phase for Both Gas Delivery Systems.  
The non-outlier range (whiskers) is defined as 1.5H below the 25th percentile or above the 75th percentile, 
where H is the height of the box or the interquartile range. Extreme outliers are denoted by asterisks (*), 











3.3.6.2 Retinal Hemodynamics 
A reduction in arteriolar diameter, blood velocity, and blood flow was observed in the hyperoxia phase 
for both gas delivery methods. The difference between the two gas delivery methods were not statistically 
significant in terms of the response for diameter (p = 0.9741), velocity (p = 0.1484), or flow (p = 0.1176). 
Additionally, there was no interaction effect between gas delivery method and phase for diameter (p = 
0.7756), velocity (p = 0.1176), or flow (p = 0.1885). In other words, retinal hemodynamics responded 
similarly during corresponding phases between the two gas delivery methods. However, the effect of 
phase was significant (p < 0.0001). Post hoc Fisher’s LSD identified significant reductions in diameter (p 
< 0.05), velocity (p < 0.05), and flow (p < 0.05) during hyperoxic provocation, when compared to 
baseline and recovery values using both methods. The mean effect during baseline and recovery for 
diameter (p > 0.05), velocity (p > 0.05), and flow (p > 0.05) were not significantly different for both gas 
delivery phases. 
 
The means and SDs of retinal hemodynamic parameters are reported in Table 3-1. Although the gas 
delivery methods did not produce significantly different retinal hemodynamic results, there was a trend 
toward a greater reduction in arteriolar diameter, blood velocity, and blood flow using the manually-
controlled system. Between baseline and hyperoxia, mean arteriolar diameter decreased by 7.8% for the 
manually-controlled system, and by 7.2% for the computer-controlled system. Mean blood velocity 
decreased by 39.6% and 28.5% for manually-controlled and computer-controlled gas systems, 




Table 3-3. Summary of Retinal Hemodynamic Parameters 
Manually-Operated Computer-Controlled  
Baseline Hyperoxia Recovery Baseline Hyperoxia Recovery 





110.1 ± 9.7 
 




110.0 ± 9.2 
 
102.1 ± 10.5 
 




32.3 ± 8.4 
 
19.5 ± 6.0 
 
30.6 ± 6.2 
 
31.2 ± 5.9 
 
22.3 ± 4.9 
 
33.6 ± 7.8 
(mm/s) 
Blood Flow  
(µL/min) 
Values expressed as mean ± SD (n = 10) 
9.5 ± 3.4 
 
4.9 ± 2.0 
 
8.9 ± 3.1 
 
9.2 ± 2.9 
 
5.7 ± 1.9 
 
9.5 ± 3.0 
 
The coefficients of variation for hemodynamic measurements, summarized in Table 3-4,  were similar 
between the two gas delivery methods but were consistently lower in all cases for the computer-controlled 
method, with blood velocity during recovery being the only exception. Lower variability of hemodynamic 
measurements produced using the computer-controlled method is especially apparent during hyperoxia, 
where smaller changes from baseline occurred. In that particular situation, mean effect values were 
greater and standard deviations were smaller compared to the values produced using the manually-
controlled method, resulting in smaller coefficients of variation. Boxplots of retinal hemodynamic 
parameters (Figure 3-6, Figure 3-7, Figure 3-8) show the presence of outliers when gas was delivered 
using the manually-controlled gas delivery system, further demonstrating higher variability of 




Table 3-4. Coefficients of Variation for Retinal Hemodynamics 
Manually-Operated Computer-Controlled  
Baseline Hyperoxia Recovery Baseline Hyperoxia Recovery 



















































Figure 3-6. Boxplot of Retinal Arteriolar Diameter at Each Phase for Both Gas Delivery Systems. 
The non-outlier range (whiskers) is defined as 1.5H below the 25th percentile or above the 75th percentile, 
where H is the height of the box or the interquartile range. Outliers are values that lie beyond the non-




Figure 3-7. Boxplot of Blood Velocity at Each Phase for Both Gas Delivery Systems.  
The non-outlier range (whiskers) is defined as 1.5H below the 25th percentile or above the 75th percentile, 
where H is the height of the box or the interquartile range. Outliers are values that lie beyond the non-




Figure 3-8. Boxplot of Blood Flow at Each Phase for Both Gas Delivery Systems.  
The non-outlier range (whiskers) is defined as 1.5H below the 25th percentile or above the 75th percentile, 
where H is the height of the box or the interquartile range. Outliers are values that lie beyond the non-












This study compared retinal vascular reactivity during an isocapnic hyperoxic provocation administered 
using a manually-controlled gas delivery system to that of a newly-developed computer-controlled 
method. The purpose of this investigation was to determine the impact of the new innovations including 
independent control of end-tidal carbon dioxide and oxygen targets and automatic breath-by-breath gas 
adjustments on retinal hemodynamic parameters measured using the CLBF.  
 
It is acknowledged that the FeO2 levels that could be achieved using the two gas delivery systems would 
differ simply due to methodology. The manually-controlled method achieved the maximal stable FeO2 
when 100% oxygen was delivered using a sequential rebreathing circuit (~85% FeO2), compared to the 
computer-controlled method, in which a 70% FeO2 (500 mmHg PetO2) target was maintained. Rather 
than attempting to match the targets between methods, as it would be difficult to manipulate FeO2 
manually to reliably maintain 70% FeO2 during hyperoxia, the maximum attainable FeO2 for both 
methods was compared in this study. The latter comparison is meaningful since the motivation for this 
study was to examine the relationship between past studies in our laboratory 18;110. These studies used an 
isocapnic hyperoxic provocation induced using the manually-controlled gas delivery system while our 
current studies employ the computer-controlled method. Statistical analysis confirmed that FeO2 levels 
differed between the two methods during the hyperoxic provocation.  
 
The target for the computer-controlled method is the maximal end-tidal oxygen level that can be achieved 
using this technique. We are confident that this is the case given the distribution of the FeO2 data around 
the median during the hyperoxia phase, shown in Figure 3-5. Extremely tight regulation of FeO2 during 
hyperoxia was evidenced by the small range (< 1%) between the 25th and 75th percentiles, and the 
presence of extreme outliers only below the median. In these cases, participants were unable to achieve 
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the 70% FeO2 target with the computer-controlled method, or experienced slight discomfort, and the 
target had to be adjusted accordingly. This upper limit is imposed by the fact that a gas mix consisting of 
safe minimum levels of O2 and N2, and safe maximum levels of CO2 for respiration are administered at all 
times. Multiple breaths are required to exchange most of the alveolar air since the volume of alveolar air 
that is replaced by atmospheric air (administered gas in this case) with each breath is only one seventh of 
the total alveolar volume 118. On this principle, it would be impossible to attain square-wave transitions 
between phases while avoiding ETCO2 drift, which is one of the characteristic goals of the computer-
controlled method, especially given the magnitude of change in FeO2 required in the transition between 
the baseline and hyperoxic levels defined in this study. Even if higher FeO2 levels were targeted at the 
expense of the square-wave transitions, the present data suggests that it would be unattainable using the 
first generation of the computer-controlled gas delivery instrument. Furthermore, sustained exposure to 
high concentrations of oxygen elicits hyperventilation 106. To achieve FeO2 targets as high as the levels 
produced by the manually-operated method using the computer-controlled method, the increased effort 
due to hyperventilation would make it intolerable for participants.  
 
Participants did not report any discomfort using the manually-controlled method of gas delivery, despite 
higher FeO2. Both systems were free-breathing rather than forced ventilation; however, the differences in 
the participant experience could perhaps be attributed to a higher standardized gas flow rate in the 
computer-controlled system, whereas with the manually-controlled system, the flow rate was driven by 
minute ventilation which is variable between individuals. 
 
Similarly, differences between the two gas delivery systems were also identified for ETCO2 levels, 
mainly due to methodology. Each participant’s normal ETCO2 was maintained only through sequential 
rebreathing using the manually-controlled system. In contrast, ETCO2 levels can be specifically targeted 
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and regulated on a breath-by-breath basis by combining the sequential rebreathing circuit with the 
computer-controlled method. While both gas delivery methods include a fresh gas and a rebreathed gas 
component, and the flow rate of each gas can be adjusted within phases, it is only with the computer-
controlled method that the gas mix can be reliably varied within a phase. As a result of this innovation, 
fewer adjustments have to be made by the user, i.e. to adjust the flow rate in the manually-controlled 
method or user-entered target overrides for the computer-controlled method, to maintain stable levels 
using the computer-controlled method.  
 
Although ETCO2 was significantly lower during the hyperoxic phase using both methods, the magnitude 
of change is physiologically negligible. A reduction of less than 1% ETCO2 during hyperoxia, as observed 
here, is in agreement with other studies involving an isocapnic hyperoxic provocation 18;55;102. Minor drifts 
in ETCO2 are virtually unavoidable when inspired oxygen is increased, particularly at maximal levels. 
Exposure to higher levels of oxygen during hyperoxia induces an increase in ventilation, increasing the 
rate of carbon dioxide elimination105;106, especially if isocapnia is maintained106. The paradoxic rise in 
ventilation rate can be partly explained by the Haldane effect, whereby increased oxygen tension reduces 
carbon dioxide-hemoglobin binding104-106. Furthermore, the constrictor effect of high oxygen tension 
slows the circulation through the cells of the respiratory centre, leading to the accumulation of the acid 
products of metabolism and oxygen free radicals that stimulate brainstem CO2/H+ chemoreceptors due to 
the accumulation of the acid products of cell metabolism, thus affecting central nervous control of 
respiration 107;108. However, sequential rebreathing, which passively matches the increases in minute 
ventilation with inhaled carbon dioxide prevents a more pronounced ETCO2 reduction that would be 
observed with non-rebreathing techniques of gas delivery102;119. Sequential rebreathing is incorporated 
into both of the gas delivery systems studied here, although the computer-controlled method incorporates 
delivery of a specific fresh gas mix to further compensate for ETCO2 drift. As such, fluctuations in 
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ETCO2 were minimized to physiologically insignificant levels in this study. Furthermore, previous studies 
on the effect of hypercapnia on retinal hemodynamics have induced a change of approximately 15% 
ETCO2 68;95;120. As such, isocapnia was essentially maintained and any changes in vessel diameter, blood 
velocity, and blood flow can reliably be attributed to variations in inspired oxygen levels.  
 
Retinal vascular reactivity measurements in response to isocapnic hyperoxia induced by the manually-
controlled gas delivery system were in agreement with a previous study on healthy participants using the 
CLBF 55. The ETCO2 and FeO2 levels attained during normoxic (baseline and recovery) and hyperoxic 
phases were comparable to those achieved in that previous study which used the manually-controlled gas 
delivery system 55, validating the data acquired in this study. We found that there was essentially no 
difference in the mean effect of end-tidal gas concentrations achieved using both gas delivery methods, 
with the exception of FeO2 during hyperoxia. As such, it was not surprising that there was no significant 
difference in retinal hemodynamic parameters when comparing baseline and recovery measurements for 
both systems. 
 
Interestingly, despite a significant interaction effect between gas delivery systems and gas phase during 
hyperoxia (ie. FeO2 was significantly different between the two gas delivery systems during that phase), it 
did not produce statistically different effects on retinal hemodynamics between the systems during 
hyperoxia. However, compared to baseline values, there was a trend toward higher arteriolar diameter, 
blood velocity, and blood flow when comparing means and SDs for the computer-controlled than the 
manually-controlled gas delivery system during hyperoxia (Table 3-3).  These differences are subtle, as it 
is evident in the boxplots Figure 3-6, Figure 3-7, and Figure 3-6. When comparing the two gas delivery 
systems that the interquartile ranges of the hemodynamic parameters overlapped during hyperoxia.  
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An important finding from this study was the reduced variability in hemodynamic parameters produced 
during each phase using a gas stimulus administered by the computer-controlled gas delivery system. This 
finding has an important implication in terms of experimental design. With reduced variability, there is 
greater sensitivity to detecting differences between and changes between groups. It is expected, then, that 
a smaller sample size would be required to achieve adequate power for detecting a statistiscal difference. 
  
A comparison between the two gas delivery systems has not been previously attempted, and as such, this 
was conducted as a pilot study to determine the amount of variation that can be expected with the mean 
effect sizes. It cannot be dismissed that a larger sample size might reveal significant differences in 
hemodynamic parameters during hyperoxia. With the current sample size of 10, post-hoc estimation of 
the statistical power of the test to reveal a difference in retinal blood flow between the two methods 
during hyperoxia is 51.5%. Based on the data from this study, it was determined that a sample size of 18 
would have adequate power (80.7%) to show a difference, assuming that a true difference does exist. 
However, since this is the first study to compare the two gas delivery systems, there was no existing data 
suggesting an adequate sample size. Hence, no further participants were recruited into the study to 
increase the sample size as a result of this analysis. 
 
Oxygen is not exclusively delivered through the retinal vasculature as it has been shown that hyperoxic 
ventilation can partly overcome intraretinal anoxia during retinal artery occlusion121. Microelectrode 
studies have characterized oxygen distribution through the retina during systemic hyperoxia in several 
animal models including rat122, mouse123, rabbit124, cat125. Studies of this nature have been limited to 
species with avascular retinas, or the occlusion of the retinal artery in species with vascular retinas. A 
multi-layer model of oxygen distribution and consumption in the retina has demonstrated an oxygen 
gradient in which choroidal oxygen tension is approximately double that of pre-retina 123. The inner 
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segments of photoreceptors, outer plexiform layer, and inner plexiform layer are the dominant oxygen 
consumers in the retina due to the high oxygen and energy requirements of synaptic activity and restoring 
ionic gradients 121. The stability of oxygen consumption during systemic hyperoxia, despite a four-fold 
increase in choroidal oxygen delivery, suggests that inner retinal oxygen consumption dramatically 
increases under such conditions in the intact retina (ie. free from retinal arterial occlusion) 126. 
Furthermore, while carbon dioxide seems to modulate choroidal blood flow, oxygen tension does not 
have an effect109;127;128. Interestingly, since periarteriolar oxygen tension in the retina has been found to 
always be greater than in the choroid, hyperoxia-induced vasoconstriction is still largely mediated by 
local oxygen tension rather than oxygen diffusing from the choroid129.  The contribution of choroidal 
oxygen to retinal arteriolar vasoconstriction cannot be resolved using the current study’s methods. 
However, perhaps the degree of oxygen uptake and diffusion to the inner retina from the choroid in 
response to different levels of systemic hyperoxia may partially account for the similar retinal blood flow 
response to different levels of inspired oxygen. 
 
It is also possible that increased oxygen delivery, beyond a certain threshold level, has no additional 
vasoactive effect on retinal circulation. The choroid can adequately supply the inner retina with oxygen 
independently of the retinal circulation during hyperbaric oxygen breathing 59;130. Dollery et. al. 59 
explains that once the arterial oxygen tension exceeds 270 mmHg, the capacity for hemoglobin to buffer 
against changes in oxygen pressure is lost, further reducing the low arteriovenous difference in the 
choroid. In spite of this, complete closure on exposure to oxygen seems to be confined to immature 
vessels 131. Although many studies have investigated the effects of hyperoxia on retinal hemodynamics, 
hyperoxia was induced by breathing 100% oxygen, few studies have shown the effects of smaller 
increases in inspired oxygen on retinal blood flow.  Given the capability of the computer-controlled gas 
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delivery system used in this study to specifically target various concentrations of inspired gas, it is ideal 




Retinal Hemodynamic Response to Incremental Changes in Hyperoxic 
Stimuli During Isocapnia 
4.1 Abstract 
 
Purpose: The high metabolic needs of the retina necessitate an efficient and precisely regulated 
mechanism in the retinal vasculature to maintain a steady supply of oxygen. Although the vascular 
reactivity response to hyperoxia has been extensively studied, most of these studies used a 100% inspired 
oxygen stimulus. The aim of this study is to explore the relationship between retinal vascular reactivity 
and incremental changes in hyperoxia during isocapnia, in addition to providing normative data for the 
retinal hemodynamic response to incremental changes in hyperoxic stimuli during isocapnia.  
 
Method: Twelve healthy, young adults participated in a gas protocol consisting of 4 phases at varying 
fractional expired oxygen levels (FeO2): baseline (15%), hyperoxia I (40%), hyperoxia II (65%), and 
recovery (15%). End-tidal carbon dioxide (ETCO2) was maintained at an isocapnic level (~ 5%) 
throughout the experiment. Retinal arteriolar diameter, blood velocity, and blood flow were assessed non-
invasively using the Canon Laser Blood Flowmeter during each of these phases.  
 
Results: Repeated measures ANOVA showed that there were significant influences of incremental 
changes in FeO2 on arteriolar diameter (p < 0.0001), blood velocity (p < 0.0001), and blood flow (p < 
0.0001) in the retina. Paired t-tests of these retinal hemodynamic parameters during each phase in the gas 
sequence showed they were significantly different (p < 0.05) from each other, with the exception of 
baseline and recovery values. Incremental increases in FeO2 caused a linear decrease in group mean 
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arteriolar diameter (R2 = 1, p = 0.002), group mean blood velocity (R2 = 0.9968, p = 0.04), and group 
mean blood flow (R2 = 0.9982, p= 0.03).  
 
Conclusions: Isocapnic hyperoxia elicits vasoconstriction and the reduction of retinal arteriolar blood 























Vascular reactivity is defined as the magnitude of change of hemodynamic parameters in response to 
provocative stimuli, such as the manipulation of the partial pressures of O2 or CO2 (pO2 or pCO2) in 
inspired gases.  Retinal blood flow varies inversely with the pO2 to maintain tissue oxygenation at a 
constant level, and also varies directly with the pCO2.  Oxygen supply to the retina during hyperoxia is 
regulated by vasoconstriction101, which is predominantly mediated by the release of endothelin-1 by 
vascular endothelial cells57. 
 
An effective method of delivering a hyperoxic stimulus while maintaining stable isocapnia through a 
sequential re-breathing circuit102 was used to evaluate the retinal vascular effect of approx  95% inspired 
oxygen in healthy participants 55. However, inhalation of pure oxygen or oxygen-enriched gas dilutes the 
blood concentration of carbon dioxide, which exaggerates the vasoconstrictive effect of oxygen in retinal 
vasculature112. Maintaining isocapnia allows the true effect of elevated blood concentration of oxygen to 
be studied 95. A computer-controlled gas sequencer, in conjunction with the sequential rebreathing circuit, 
allows the automated controlled delivery of oxygen through breath-by-breath adjustments to the delivered 
gas mixture 132.  
 
The comprehensive study of hemodynamics in the human retina requires the use of techniques that allow 
the non-invasive, quantitative measurement of blood flow. Using the Canon Laser Blood Flowmeter, it is 
now possible to simultaneously assess retinal vessel diameter and quantify centerline blood velocity using 
bidirectional laser Doppler velocimetry to derive volumetric retinal blood flow in absolute units, non-
invasively. This offers an advantage over previous studies of ocular blood flow and vascular reactivity in 
the human retina which had technical issues including the assignment of arbitrary units to blood flow or 




The study described in the previous chapter compared retinal hemodynamic changes to the maximum 
hyperoxic provocation that can be delivered using a manually-controlled gas delivery system and the 
computer-controlled gas sequencer. Although there was a >15% difference in FeO2 during maximum 
hyperoxic provocation between manually-controlled (85.27 ± 0.29%) and computer-controlled (69.02 ± 
2.84%) gas delivery systems, the retinal hemodynamic response from normoxia in terms of arteriolar 
diameter, blood velocity, and flow were not significantly different. From these results, the nature of 
vascular reactivity in the human retina in response to systemic hyperoxia is unclear. It could perhaps be 
an indication that there is a threshold effect, whereby there is a decreased ability of retinal vessels to 
autoregulate against changes in arterial oxygen tension beyond a certain concentration. 
 
The primary aim of the study is to assess the retinal arteriolar vascular response to incremental increases 
in inspired O2 at isocapnia in healthy participants.  It is hypothesized that incremental oxygen delivery 
will result in incremental changes in retinal arteriolar blood flow. The study may provide insight into the 
rate of change of retinal blood flow relative to changes in FeO2.  
 
4.2 Materials and Methods 
4.2.1 Participants 
Fourteen adults were recruited into the study but the data from two were excluded due to poor fixation 
during imaging and inadequate gas control (ie. Inability to stabilize FeO2 and ETCO2 during CLBF 
measurements due to fatigue). Of the12 participants whose data was included in the analysis, there were 6 
men and 6 women, ranging in age from 19 to 34 years (mean age 26.2 years, SD ± 4.08). All participants 
had 20/20 visual acuity or better. Participants were excluded if they had a refractive error of >± 6.00 DS 
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and /or ± 2.50 DC, ocular disease or disorder including lenticular opacity, and a history of intraocular or 
refractive surgery in order to avoid light scatter that may interfere with imaging 91. Additional exclusion 
criteria included existing or a history of endocrine disease, and systemic disease including respiratory 
disorders, cardiovascular disease, and hypercholesterolemia. Current cigarette smokers or anyone who 
had ceased smoking for less than 6 months prior to study participation were also excluded from the 
study114. Participants were asked to abstain from caffeine for 24 hours prior to their involvement in the 
study113. The study received the approval of the University of Waterloo Office of Research Ethics. 
Informed consent was obtained from each participant after thorough explanation of the nature of the study 
and its possible consequences, according to the tenets of the Declaration of Helsinki. 
 
4.2.2 Sample Size Rationale 
Existing data from our lab shows that retinal blood flowed at a rate of 9.4 μL/min at baseline normoxic 
conditions (FeO2 = 15%) and 5.1 μL/min during isocapnic hyperoxia (FeO2 =85%), with a mean 
difference of 4.3 μL/min (SD 1.9)55. The standardized effect size for each FeO2 interval was defined as 
the mean change in retinal blood flow divided by the standard deviation.  For the purpose of this study 
normoxia was defined as 14% FeO2. Assuming a linear relationship between FeO2 and retinal blood flow, 
interpolation of these results estimated the expected blood flow and standardized effect sizes during each 
defined hyperoxic stimulus as summarized in Table 4-1. 
 
Table 4-1. Expected Blood Flow and Standardized Effect Sizes.  
ΔFeO2 Δ Retinal Blood Flow Standardized Effect Size 
14% to 40% -2.0 μL/min 1.0 




For a standardized effect size of 1.0, an α-level of 0.05, and a β-level of 0.1, the requisite sample size for 
statistical significance is n = 11. Since there are two possible randomized sequences in this study, sample 
size was increased to n = 12 so that each of these sequences could be used randomly but equally.  
 
4.2.3 Pre-data Collection Screening 
Prior to data collection, a screening was performed to ensure that each participant met the study criteria. 
A medical history was taken with questions pertaining to the aforementioned exclusion criteria. Blood 
pressure and pulse measurements were also taken using an automated sphygomanometer (Omron Digital 
Blood Pressure Monitor HEM-907, IntellisenseTM). 
 
Visual acuity was measured with the Early Treatment of Diabetic Retinopathy Study (ETDRS) logMAR 
charts. 
 
Prior to CLBF data acquisition, a drop of fluorescein was applied to the cornea to detect corneal abrasions 
or tear film irregularities that may interfere with CLBF imaging. Ophthalmic drops were used only if 
study participants reported no known allergies to the drugs. Van Herrick’s angle assessment was 
performed to determine the risk of anterior angle closure, prior to the use of mydriatic drops. Once it was 
determined that mydriasis was safe (ie. cornea to chamber ratio > 1:1/2), one drop of 1% Tropicamide 
was applied to the randomly chosen study eye. 
 
4.2.4 Gas Delivery  
The computer-controlled gas delivery system that was described in the previous chapter was used for the 
study. Briefly, the system incorporates a sequential re-breathing circuit102 with a computerized end-tidal 
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gas monitoring system that regulates the flow of O2, CO2, and N2 to the participant on a breath-by-breath 
basis, according to pre-specified PetO2 and PetCO2 targets116. For this study, the computer-controlled 
system was favoured over the manually-controlled system for several reasons. Firstly, as demonstrated in 
the previous study, the computer-controlled system normalizes PetCO2 across participants and over time. 
Secondly, the computer-controlled system more tightly regulated PetO2 during hyperoxia, reducing the 
variation in retinal hemodynamic measurements between participants. In addition, the computer-
controlled system was designed to clamp CO2 and O2 independently of each other, irrespective of the 
ventilation rate, which can be affected by prolonged hyperoxic exposure. Due to this specific targeting, 
square waveform patterns can be achieved during the gas transitions, allowing gas targets to be met in a 
timely fashion 132. Furthermore, the hyperoxic stimulus was limited to maximal FeO2 levels for each 
participant and cannot be specifically targeted. As the aim of the study was to provide normative retinal 
hemodynamic data for incremental changes in FeO2, the computer-controlled system was the appropriate 
choice. 
 
4.2.5 Retinal Hemodynamic Measurements 
Retinal hemodynamic measurements were taken noninvasively with the Canon Laser Blood Flowmeter 
(CLBF). A measurement site was chosen approximately one disc diameter from the optic nerve head in 
the superior temporal arteriole. The CLBF simultaneously measures vessel diameters and red blood cell 
velocity through the measurement site and derives volumetric blood flow. Since these calculations assume 
Poiseuille’s flow (non-turbulent flow) and a circular vessel profile, measurement sites were chosen in a 
relatively straight segment of the arteriole that was free of bifurcations. 
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4.2.6 General Protocol 
Participants were fitted with a face mask and a gas delivery system comprising a sequential rebreathing 
circuit through which they breathed a controlled mixture of gases. The sequential rebreathing circuit 
consisted of fresh and rebreathed gas reservoirs. A transparent medical film dressing (3MTM TegadermTM, 
St. Paul, MN) was used to secure the mask and to create an airtight seal around the face. 
 
A gas sequence consisting of four phases – baseline, hyperoxia I, hyperoxia II, and recovery – was used 
to stimulate retinal hemodynamic changes. End-tidal CO2 was targeted at approximately 5% and 
maintained throughout the phases. The FeO2 levels that were targeted in each phase are summarized in 
Table 4-2. 
 
Table 4-2. FeO2 Targets Defined in the Study 
Phase FeO2 Target 
Baseline 15% 
Hyperoxia I 40% 




Participants were randomly assigned to one of two sequences (Figure 4-1), which differed only in the 
order in which the Hyperoxia I and Hyperoxia II phases were administered, and were masked to which 
sequence they were given. Vasoconstriction has been shown to persist within 10 minutes after cessation 
of a hyperoxic stimulus133, likely due to the relatively long half-life of ET-157;58;134. The design of this 
study negates the potential influence of an order effect by randomizing the order of the hyperoxia phases, 
which may vary in the persistence of vasoconstriction after removal of the hyperoxic stimulus due to the 
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differences in FeO2 elevation. A stabilization period (10 minutes) was allowed after each hyperoxic phase 
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Figure 4-1. Gas Sequence for Study Protocol.  
Hyperoxia I and II were presented in random order such that each participant received either the treatment 
represented in A or B. Isocapnia is maintained throughout the protocol, as indicated by the flat blue line 
(CO2). The red line (O2) reflects changes in FeO2 which was targeted at 40% and 65% for the Hyperoxia I 
and II phases, respectively and 14% for Baseline and Recovery phases. FeO2 and ETCO2 are simply 
expressed as percentages of PetO2 and PetCO2 over atmospheric pressure (760 mmHg). 
 
 
Before commencing data collection, participants were asked to rest for at least 20 minutes to ensure that 
all metabolic parameters were representative of baseline, resting conditions. Once the gas mask was 
attached, participants breathed air that was delivered through the mask until their tidal volumes of CO2 
and O2 were stabilized, upon which the gas sequence was initiated. PetCO2 and PetO2 levels were allowed 
to stabilize at the start of each phase before CLBF measurements were made. More importantly, if the 
particular phase was preceded by one with a higher targeted PetO2 a period of at least 10 minutes would 
be allowed, as long as it did not affect the participant’s reported comfort. The additional time was 
required since it was found in a previous study in our lab and others that hyperoxic provocation resulted 
in a persistent vasoconstriction up to 10 minutes after cessation of the stimulus (unpublished data, paper 
in submission)101;133. During each phase, 6 CLBF measurements were taken at 1 minute intervals. 
 
4.2.7 Data Analysis 
4.2.7.1 Gas Data 
End-tidal gas parameters were recorded directly by a computer-controlled gas delivery system on a 
breath-by-breath basis. PetO2 and PetCO2 were reported in mmHg, and were converted to FeO2 and 




Upon plotting FeO2 and ETCO2 against time (min), any values derived during the transition between 
normoxic and hyperoxic phases were excluded. Data points lying outside the 10th and 90th percentiles (ie. 
3 SDs from the mean) of each phase were excluded as outliers, and were likely the result of 
misinterpretation of the tidal waveforms by the gas monitor. 
 
4.2.7.2 CLBF Data 
A post-acquisition analysis of the velocity waveforms were performed using a standardized protocol to 
remove aberrant waveforms affected by eye movements, tear film breakup, or improper tracking of the 
measurement laser. Velocity waveforms were accepted if there was a minimum of one complete cardiac 
cycle which was not adversely affected by major eye movements, ie. more than 50 μm in each direction. 
 
4.2.7.3 Statistical Analysis 
Differences in end-tidal gas parameters (ETCO2 and FeO2) for each phase (baseline, hyperoxia, and 
recovery) were analyzed using repeated measures ANOVA (reANOVA) Similarly, differences in retinal 
hemodynamic parameters (blood vessel diameter, blood velocity, and blood flow) were analyzed using 
reANOVA for each phase. Regression analysis was performed to explore the relationship between FeO2 
and group mean hemodynamic measurements. 
 
4.3 Results 
4.3.1 End-Tidal Gas Parameters 
Repeated measures ANOVA showed that ETCO2 was significantly different between subjects (p < 
0.0001). However, there was no significant effect of the phases in the gas sequence (p = 0.3271), 




For FeO2, reANOVA showed that differences between subjects was not significant (p = 0.4559). The 
effect of the phases in the gas sequence was found to be significant (p < 0.0001). Post hoc t-tests (LSD) 
showed that FeO2 was significantly different between each pair of phases (p < 0.05), except for the 
comparison between baseline and recovery FeO2 levels. Mean FeO2 at baseline was 14.24 ± 0.34%, and 
each successive phase increased linearly by 25% increments to 39.74 ± 0.34% and 64.65 ±1.47% for 
hyperoxia I and hyperoxia II, respectively. The means and SDs values for ETCO2 and FeO2 levels are 
summarized in Table 4-3 and boxplots are show in Table 4-2 and Table 4-3 . 
 
Table 4-3. Summary of End-Tidal Gas Parameters. 
 Baseline Hyperoxia I Hyperoxia II Recovery 
ETCO2 5.59 ± 0.62 5.54 ± 0.57 5.52 ± 0.54 5.62 ± 0.58 
FeO2 14.24 ± 0.34 39.74 ± 0.34 64.65 ± 1.47 14.30 ± 0.30 





Figure 4-2. Boxplot of ETCO2. 
The non-outlier range (whiskers) is defined as 1.5H below the 25th percentile or above the 75th percentile, 
where H is the height of the box or the interquartile range. Extreme outliers are denoted by asterisks (*), 





Figure 4-3. Boxplot of FeO2. 
The non-outlier range (whiskers) is defined as 1.5H below the 25th percentile or above the 75th percentile, 
where H is the height of the box or the interquartile range. Outliers are values that lie beyond the non-
outlier range and are denoted by open circles (○).Extreme outliers are denoted by asterisks (*), indicating 










4.3.2 Retinal Hemodynamics 
Relative to baseline, a reduction in arteriolar diameter, blood velocity, and blood flow was observed 
during hyperoxia I and hyperoxia II. Difference in each of the retinal hemodynamic parameters between 
participants was significantly different (p < 0.0001 for diameter, velocity, and flow). The effect of the gas 
phases on each of the retinal hemodynamic parameters was also significant (p < 0.0001 for diameter, 
velocity, and flow). The group means and standard deviations for arteriolar diameter, blood velocity, and 
blood flow by gas phases (baseline, hyperoxia I, hyperoxia II, and recovery) are reported in Table 4-4. 
Boxplots for each of these parameters are shown in Figure 4-4, Figure 4-5, and Figure 4-6. 
 
 
Table 4-4. Summary of Retinal Hemodynamic Parameters. 
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Figure 4-4. Boxplot of Retinal Arteriolar Diameter.  
The non-outlier range (whiskers) is defined as 1.5H below the 25th percentile or above the 75th percentile, 





Figure 4-5. Boxplot of Retinal Blood Velocity. 
The non-outlier range (whiskers) is defined as 1.5H below the 25th percentile or above the 75th percentile, 





Figure 4-6. Boxplot of Retinal Blood Flow.  
The non-outlier range (whiskers) is defined as 1.5H below the 25th percentile or above the 75th percentile, 
where H is the height of the box or the interquartile range. Outliers are values that lie beyond the non-














Retinal arteriolar diameter decreased with incremental hyperoxia. A pairwise comparison of the gas 
phases using a t-test showed that with the exception of the baseline to recovery comparison, all other pairs 
of phases were significantly different in terms of retinal arteriolar diameter (p < 0.05). Hyperoxia II 
produced a greater reduction in diameter relative to baseline (-7.82%) than hyperoxia I (-3.94%). 
 
A similar pattern of reduction was observed in the velocity of red blood cells traveling through the 
sampling site. With the exception of the baseline to recovery comparison, pairwise comparisons of 
velocity during each gas phase using the t-test showed that each phase was significantly different (p < 
0.05). Relative to baseline, hyperoxia I and hyperoxia II produced changes in velocity of -13.3% and -
29.3%, respectively. 
 
Retinal blood flow followed the same pattern of reduction in the face of increases in inspired oxygen 
stimulus. All pairwise comparisons using t-tests of retinal blood flow during each pair of gas phases were 
significantly different (p < 0.05), although baseline and recovery were the same. Incremental increases in 
FeO2 produced reductions in flow such that hyperoxia I changed by -1.8% and hyperoxia changed by -
2.1%, relative to baseline. 
 
4.3.3 Correlation Between Group Mean FeO2 and Group Mean Retinal Hemodynamic 
Parameters 
When group means of retinal arteriolar diameter, blood velocity, and blood flow were each plotted against 
the group mean of FeO2 (for all phases minus recovery), each of the retinal hemodynamic parameters were 
significantly varied inversely with changes in FeO2. Diameter (R2 = 1, p = 0.002), velocity (R2 = 0.9968, 
p = 0.04), and flow (R2 = 0.9982, p = 0.03) had strong linear correlations with FeO2. Data from individual 




With FeO2 as the independent variable and retinal arteriolar diameter (RAD), retinal blood velocity 
(RBV), and retinal blood flow (RBF) as dependent variables, retinal hemodynamics are generally related 
to FeO2 by the following equations, and illustrated in Figure 4-7. Despite differences in R2 values, the 
equation from the linear regressions remain the same whether they include only the group mean data or 
the individual data. 
 
RAD = -0.17 FeO2 + 113 
RBV = -0.19 FeO2 + 36 
RBF = -0.08 FeO2 + 11 
 
 
Figure 4-7. Linear Regression of Group Mean Retinal Hemodynamic Parameters Against Changes 





The primary aim of this study was to define the retinal hemodynamic response to incremental changes in 
systemic hyperoxia during isocapnia. The data strongly demonstrates that retinal arteriolar diameter, 
blood velocity, and blood flow varies inversely and linearly with incremental changes in FeO2.   
 
It is generally accepted that incremental changes in end-tidal partial pressures of O2 and CO2 correlate 
well to systemic arterial O2 and CO2 tension which varies by the proximity of the peripheral sampling site 
to the lungs 112. Expired gases (FeO2 and ETCO2) can thus be validly used as surrogate measures of the 
partial pressures of O2 and CO2 in arterial blood. Incremental changes in end-tidal partial pressures of O2 
and CO2 are also believed to more closely reflect the metabolic rate than inspired gas. In this study, 
ETCO2 was maintained throughout the experimental protocol within subjects, so changes in retinal 
arteriolar diameter, blood velocity, and blood flow can be attributed to changes in FeO2. Although 
baseline ETCO2 varied significantly between participants, it is likely that the high degree of control of 
end-tidal gases within subjects amplified the individual variation between participants. On average, 
ETCO2 was maintained at close to 5%, a level which is considered normocapnic. 
 
Based on the slopes of the linear regressions, for every 1% increase in FeO2 within the limits of this study 
(~ 15% to 65% FeO2), retinal arteriolar diameter decreased by approximately 0.17 µm, velocity decreased 
by approximately 0.19 mm/s, and flow decreased by approximately 0.08 µL/min. Based on the mean 
retinal hemodynamic measurements at normoxia, this represents a 0.15% decrease in arteriolar diameter, 
a 0.57% decrease in blood velocity, and 0.82% decrease in blood flow. Increases in FeO2 have the 
greatest effect on blood flow, due to the compound effect of decreases in both vessel diameter and 
centerline blood velocity. This is not surprising because according to Poiseuille’s law of non-turbulent 
flow (which is assumed in the small blood vessels measured by the CLBF), the fourth power of the radius 
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is directly related to the rate of flow. Small changes in diameter would thus result in greater changes in 
flow. 
 
Regression analysis of the group means of each of the hemodynamic parameters across baseline (14.24 ± 
0.34% FeO2), hyperoxia I (39.74 ± 0.34% FeO2), and hyperoxia II (64.65 ± 1.47% FeO2) yielded results 
that indicated nearly perfect linear correlation between FeO2 and arteriolar diameter (R2 = 1, p = 0.002)), 
blood velocity (R2 = 0.9968, p = 0.04), and blood flow (R2 = 0.9982, p = 0.03). Since baseline and 
recovery phases were not significantly different for gas nor hemodynamic parameters, values from the 
recovery phase were excluded from the regression analysis to avoid doubling the sample points for the 
normoxic condition. When regression analysis was performed using data from the individual participants 
(rather than a group mean), similar linear relationships were found. Given this evidence, we have 
demonstrated that retinal blood flow is reduced in a linear manner in the presence of systemic hyperoxia 
(over the range of 15 – 65% FeO2) and isocapnia, due to the linear reduction of arteriolar diameter and 
blood velocity. 
 
A recent study in our lab has identified a persistent vasoconstrictive effect of hyperoxia within 10 minutes 
after the cessation of the stimulus133. Although it was beyond the scope of that particular study to 
determine the underlying cause, it was speculated that endothelin-1 (ET-1), a potent endothelium-derived 
vasoconstricting agent which mediates hyperoxia-induced vasoconstriction was responsible. Studies to 
date suggest that the half-life of ET-1 could be as short as 1.4 to 3.6 minutes, or as long as 35 minutes134. 
It has also been suggested that persistent vasoconstriction following pronounced hyperoxia (ie. 





Several precautionary measures were taken in order to avoid the confounding effects of persistent 
hyperoxia-induced retinal vasoconstriction in this study. First, hyperoxia I (target FeO2 = 40%) and 
hyperoxia II (target FeO2 = 65%) phases were administered in random order.  Furthermore, at the 
transition between phases, when FeO2 was either raised or lowered, a 10 minute period of breathing was 
allowed before CLBF measurements were taken – although in some cases, this time period had to be 
abbreviated depending on the participant’s reported discomfort with the procedure. Since the recovery 
values for arteriolar diameter, velocity, and flow were not significantly different from the baseline values, 
it is reasonable to conclude that the hemodynamic response during each phase is independent of other 
phases in the gas protocol. 
 
Although it might have been informative to include more levels of hyperoxia in the study protocol, this 
was limited by the fact that subjects could not comfortably tolerate the amount of time required to do so. 
However, given the high degree of correlation as indicated by the R2 values, it is unlikely that inserting 
more phases within the existing FeO2 intervals would change this relationship. The FeO2 levels chosen for 
this study encompasses a range between normoxia and a level that approaches the upper limit for the 
majority of participants for this particular method of hyperoxia induction. In the study presented in 
Chapter 3, the same gas delivery method (computer-controlled) produced a level of hyperoxia of 69.02 ± 
2.84% FeO2, although several of the participants could not reach the 70% FeO2 target. The hyperoxia 
protocol for the manually-controlled gas delivery system was designed to target the maximum FeO2 in 
each participant, achieving a group mean of 85.27 ± 0.29% FeO2. This study was originally intended only 
for the comparison of the retinal hemodynamic response to a hyperoxic stimulus administered using two 
different gas delivery systems. However, since FeO2 during hyperoxia was significantly different when 
comparing the two systems hemodynamic data from this study was used as additional coordinates for 
regression analysis to explore the relationship between FeO2 and hemodynamics in the 65% to 85%, 
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given that linearity was established in the 15% to 65% FeO2 range. When these additional coordinates 
were included in the regression analysis, the linear relationship between FeO2 and the retinal 
hemodynamic response was preserved (Figure 4-8). The correlations for arteriolar diameter (R2 = 0.9314), 
blood velocity (R2 = 0.9980), and blood flow (R2 = 0.9909) were very strong and comparable to the 
regression using only the coordinates of the current study. The slopes and intercepts for each remained the 
same for the blood velocity response, and remained very similar for arteriolar diameter, and blood flow, 
as shown in the equations below. 
RAD = -0.13 FeO2 + 111 
RBV = -0.19 FeO2 + 36 




Figure 4-8 Linear Regression of Group Mean Retinal Hemodynamic Parameters Against Changes 




Since regression analysis strongly suggests that linearity between FeO2 and arteriolar hemodynamics is 
maintained, then it follows that the retinal hemodynamic parameters were each reduced at the same rate 
when FeO2 rises in the 65-85% range as it did between the 15-65% range. This finding is interesting in 
light of the fact that retinal arteriolar diameter, blood flow, and blood velocity at 70% and 85% FeO2 were 
not significantly different. Prior to the current study which investigated incremental changes in FeO2, the 
results might have suggested that the hemodynamic response reached a plateau during pronounced 
systemic hyperoxia. The current evidence would suggest that this does not occur within the studied range. 
The previous study (Chapter 3)  showed a trend of a greater reduction from baseline of all the 
hemodynamic parameters using the manually-controlled gas delivery system because of a higher group 
mean FeO2, even if this difference was not statistically different. It is likely that a statistical difference 
was not found because the interval between the two hyperoxic phases was much smaller than the interval 
between the hyperoxic and normoxic phases. The previous study needs to be interpreted with caution 
because of the relatively small sample size used. 
  
Based on this evidence, it is reasonable to conclude that when systemic oxygen tension  varies between 
15% (normoxia) and 85% FeO2, retinal arteriolar diameter, blood velocity, and blood flow are related to 
FeO2 inversely and linearly when ETCO2 is maintained at a normocapnic level. We acknowledge that the 
limitations of this post hoc combination of data from the two studies. A different gas delivery system was 
used to attain the data during the highest level of hyperoxia. Furthermore, the data was collected under 
different circumstances, and on a different group of participants (although the participants from both 
studies met the same inclusion criteria). The studies were also different in sample size, making the data 
imbalanced. This suggests a theoretical linear relationship within the 15-85% FeO2 range, and provides a 
basis for further study. A plateau effect at FeO2 levels that surpasses the range studied here cannot be 
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ruled out completely. However, with the available gas delivery techniques, it is not possible to study the 
retinal hemodynamic response at higher FeO2 levels. 
 
To the best of our knowledge, no other group has investigated the effect of incremental hyperoxia during 
isocapnia on retinal vascular reactivity. In most studies, O2 status changes are stimulated by breathing air 
to 100% O253;70;93-101; hence, a curvilinear relationship between FeO2 and retinal hemodynamics cannot be 
excluded. Other studies have reported graded changes in retinal hemodynamic parameters with graded 
increases of inhaled O298;100 in a linear manner from hypoxic to hyperoxic ranges98, but did not employ 
gas delivery techniques that could regulate gas exchange to standardized systemic pO2 and pCO2 
conditions between subjects 98;100. Isocapnia was not maintained98;100, and even deliberately altered to 
simultaneously induce hypercarbia100.  No surrogate measures of arterial O2 and CO2 tension were 
reported to reflect the systemic response to these provocations in some cases98.  Previous studies induced 
changes in FeO2 by breathing gases consisting of a range from 85% to 100% O2 but induced further 
changes in vascular reactivity by simultaneously varying CO298. Moreover, retinal arteriolar diameter and 
retinal blood velocity could not be simultaneously measured using some techniques100, and blood flow 
could only be measured in arbitrary units in others98. Given that our methodology offers superior control 
of gas delivery and simultaneous measurement of vessel diameter and blood velocity89;90, it presents a 
more accurate representation of the autoregulatory capacity of retinal arterioles to changes in systemic O2 
tension. 
 
From this study, it can be concluded for the first time that there is linear relationship between RBF and 
FeO2 in the 15% (normoxia) to 65% during isocapnia. Additional data from the earlier study strongly 
suggests that the linearity of the response extends up to 85% FeO2. The focus of further studies should be 
to assess changes in retinal vascular autoregulatory dysfunction during graded isocapnic hyperoxic 
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provocation as it may be more relevant in understanding the etiology of retinal diseases with vascular 
involvement. The gas provocation protocol described in this study could be used to identify subtle 








Vascular reactivity to hyperoxia is an important area of research as an impaired magnitude of response 
has been associated with glaucoma111, and diabetic retinopathy18. Past studies have demonstrated a 
profound vasoconstriction of retinal arterioles during hyperoxic provocation53;70;93-101. When stimulated by 
pure oxygen breathing, systemic hyperoxia results in a decrease in systemic pCO2 levels or 
hypocapnia63;102. Carbon dioxide is a potent vasodilator which results in increased blood flow to the retina 
66;96. Consequently, the combined effect of hypocapnia and hyperoxia results in a more exaggerated 
degree of vasoconstriction and decline in blood flow rate in the retinal vasculature55;102. Without 
controlling against decreases in systemic pCO2 levels during hyperoxia, retinal vascular reactivity against 
changes in systemic pO2 cannot be isolated. Maintaining isocapnia between baseline and hyperoxic 
conditions is a technically complicated matter that has been attempted in a few studies by co-
administration of CO2 or with the use of  a sequential rebreathing circuit55;102. The reduction of 
hemodynamic variables relative to baseline during hyperoxia stimulated by the systemic rebreathing 
circuit was reported to be smaller than previous studies due to the fact that isocapnia was maintained 
throughout the study protocol55;102.  Furthermore, administration of a gas stimulus using the sequential 
rebreathing circuit produced less variability in retinal hemodynamic measurements than other methods, an 
additional benefit to better stimulus control55 that should improve the statistical power of the provocation.  
 
Although the sequential rebreathing circuit provided superior control of ETCO2, a surrogate measure of 
systemic pCO2, it is not capable of providing precise incremental changes in FeO2. The first study 
(Chapter 3) comparing the magnitude and variability of the retinal hemodynamic response to isocapnic 
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hyperoxia induced by the manually-operated sequential rebreathing system to the computer-controlled gas 
delivery system confirmed this point. The quartile range for FeO2 during hyperoxia was 10.25% for 
manually-operated system compared to 0.33% for the computer-controlled system. Furthermore, the COV 
for FeO2 during hyperoxia was higher for the manually-operated system than it was for computer-
controlled system, at 6.6% vs. 4.1%, respectively. The hyperoxic FeO2 values were significantly higher 
for the manually operated method than the computer-controlled method. The computer-controlled method 
produced a lower FeO2 (69.02 ± 2.84%) than the computer-controlled method (85.27 ± 5.61%) because 
pure O2 was not used as one of the gas mixtures supplying the computer-controlled system. Baseline 
values of FeO2 were not significantly different between the two gas delivery methods. However, 
variability of normoxia (baseline) FeO2 values was similarly lower using the computer-controlled system, 
albeit less pronounced. The quartile ranges were 0.39% vs.0.33%, and the COVs were 1.9% vs. 1.4% for 
the manual versus computer-controlled systems. Due to the specific targeting of FeO2, the computer-
controlled gas delivery system is capable of standardizing the hyperoxic stimulus across participants 
within a study while also reducing variability. 
 
Isocapnia was maintained throughout the gas sequence using both methods of gas delivery. Although the 
ETCO2 levels during hyperoxia were found to be statistically different from baseline and recovery values, 
the magnitude of this difference (< 1%) was small enough that it would not have caused an appreciable 
effect in the retinal vasculature. Interestingly, while the computer-controlled gas delivery system is 
capable of achieving specific ETCO2 targets, lower variability in ETCO2 was observed with the manually-
operated system. Although ETCO2 levels were statistically different between the two gas delivery 
systems, again, the magnitude of the difference in all phases was small (~0.5%) and unlikely to affect 




Despite the differences in end-tidal gas parameters described here, Chapter 3 suggests that these 
differences had no significant effect on the magnitude of retinal hemodynamic measurements during each 
of the conditions in the gas sequence when comparing the two gas delivery systems. Retinal arteriolar 
diameter, red blood cell velocity, and blood flow were generally reduced during hyperoxia but despite the 
differences in the FeO2 levels that were achieved during hyperoxia using the two different methods of gas 
delivery, no magnitude of response differences were found between the two methods. Retinal 
hemodynamic measurements were not significantly different during the baseline and recovery phases, but 
these results were expected since differences between the two systems during these phases were less than 
1% FeO2. However, the interpretation of the results needs to take into account inherent limitations 
associated with the relatively small sample size, especially in relation to the equivalence of the magnitude 
of the vascular reactivity response between gas delivery systems. 
 
Importantly, although the magnitude of retinal hemodynamic measurements was the same between the 
gas delivery methods, variability was reduced with the computer-controlled method as demonstrated by 
lower COVs for the majority of conditions. Reduced variability in retinal hemodynamic measurements 
reflect the better control of FeO2 levels. The computer-controlled gas delivery system offers the additional 
advantage of achieving square-wave transitions between baseline and hyperoxia (up to almost 70% FeO2) 
while preventing drifts in ETCO2 levels 132. In contrast, transitions between baseline and hyperoxia are 
more gradual with the manually-operated system with transient drifts in ETCO2. Without a computerized 
system that specifically targets FeO2 and ETCO2 levels, the manually-operated system relies strictly on 
sequential rebreathing to attain the targets. Square-wave transitions between baseline and hyperoxia 
phases offer two advantages. Firstly, the targeted end-tidal gas levels can be reached more quickly so 
experiments can be carried out more efficiently without compromising the comfort and safety of the 
participant. Secondly, shorter transitions between phases ensure that the conditions under which 
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hemodynamic measurements are made are more consistent between subjects by negating the impact of 
gas delivery time on speed of the retinal vascular reactivity response. This suggests that more reliable 
hemodynamic data can be acquired when hyperoxia is induced using the computer-controlled gas delivery 
system than with the manually-operated gas delivery system.  
 
Given the technical advantages of using the computer-controlled gas delivery system identified in Chapter 
3, this device was selected for the investigation of retinal vascular reactivity to incremental changes in 
hyperoxia in Chapter 4. As demonstrated in Chapter 3, improved end-tidal gas control resulted in reduced 
variability of retinal hemodynamic parameters. Reduced variability translates into greater sensitivity for 
detecting differences or changes, hence, requiring a smaller sample size to achieve adequate statistical 
power. Unlike previous studies of graded hyperoxia, ETCO2 was controlled throughout the protocol for 
the first time. This was made possible by the control of ETCO2 independently of FeO2, and vice versa, 
and independent of minute ventilation of individual participants. The computer-controlled gas delivery 
system also allowed for the precise incremental administration of hyperoxia without interruption. With 
isocapnia maintained throughout the protocol, the influence of incremental changes in systemic pO2 
(consisting of 15%, 45%, and 65% FeO2) on vascular reactivity was isolated. 
 
In the range that was studied in Chapter 4, retinal arteriolar diameter, blood velocity, and blood flow 
differed significantly with changes FeO2. This shows that smaller changes in FeO2 can indeed elicit a 
detectable response in vascular reactivity using a relatively small sample size (n = 12). The study also 
establishes the linearity of the relationship between each of the retinal hemodynamic measurements and 
FeO2. The correlation is very strong for all parameters. Incremental increases in FeO2 caused a linear 
decrease in group mean arteriolar diameter (R2 = 1, p = 0.002), group mean blood velocity (R2 = 0.9968, p 
= 0.04), and group mean blood flow (R2 = 0.9982, p= 0.03) within the 15% to 65% FeO2 range. Although 
 
94 
it would have been useful to include more increments of FeO2 in the study design, only four phases 
representing three different FeO2 levels were investigated, since most participants could not comfortably 
tolerate a longer experiment. Given the strength of the correlation, it is unlikely that additional increments 
would change this relationship. Unique to this study, incremental changes excludes the possibility that the 
inverse relationship between FeO2 and retinal hemodynamic parameters is curvilinear in nature. In the 
interest of exploring this relationship further, data from Chapter 3 was included in a separate regression 
analysis, such that retinal hemodynamic parameters measured at 70% and 85% FeO2 were also included. 
When this data was included, the relationship was still unequivocally linear for retinal arteriolar diameter 
(R2 = 0.9314), blood velocity (R2 = 0.9980), and blood flow (R2 = 0.9909). While regression analysis 
clearly shows that the relationship between FeO2 and retinal hemodynamics is linear for the range 15 to 
85% FeO2, this conflicts with the finding that retinal hemodynamic measurements were not significantly 
different between 70% (manually-operated) and 85% (computer-controlled) FeO2. The fact that retinal 
hemodynamic measurements were found to be the same at 70% and 85% FeO2 could be interpreted in 
two ways: 1) that there is possibly a plateau effect at the upper hyperoxic limits, or 2) that linearity is 
maintained at the upper hyperoxic limits the study failed to find a significant difference because of sample 
size limitations. The second interpretation would agree with an earlier report, but that study was limited 
by the fact that end-tidal gases were not measured so it was difficult to determine the level of systemic 
hyperoxia that was elicited by each of the gas stimuli 98. Furthermore, CO2  levels were not controlled in 
this study and confounded the results98. However, given that the highest level of hyperoxia was induced 
by pure O2 breathing, the study achieved the upper hyperoxic limit and still found a linear relationship. 
The latter regression analysis as described in 4.4 was performed on data that were collected on different 
occasions, using different gas delivery methods, and on a different sample of people (though with the 
same inclusion and exclusion criteria). However, given the strength of the correlation, it is reasonable to 
state that the relationship of vascular reactivity is linear throughout the 15-85% FeO2 range. More recent 
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innovations on the computer-controlled gas delivery system will allow higher FeO2 targets to be used to 
confirm these results. This was achieved by altering the compositions of the source gases to include a 
higher concentration of O2. 
 
In conclusion, improved control of end-tidal gases using a computer-controlled gas delivery system has 
reduced the variability of hemodynamic measurements in retinal vascular reactivity studies. This 
improvement renders the techniques employed here more sensitive to detecting changes or differences in 
different populations or conditions. This thesis demonstrated for the first time that the inverse relationship 
between hyperoxia and retinal hemodynamic parameters is linear within the studied range (15%-65% 
FeO2) during isocapnia. The isocapnic condition is important so that systemic CO2 does not confound the 
effect of systemic O2. This study on young, healthy adults provides normative data against which future 




List of Abbrevations 
DC Dioptres cylinder 
DS Dioptres sphere 
ETCO2 End-tidal carbon dioxide (% of atmospheric pressure) 
FeO2 Fractional expired oxygen (% of atmospheric pressure) 
logMAR Logarithm of the minimum angle of resolution 
Pa Arterial pressure 
PaCO2  Partial pressure of arterial carbon dioxide (mmHg) 
PaO2 Partial pressure of arterial oxygen (mmHg) 
pCO2 Partial pressure of carbon dioxide  
PEEP Positive End-Expiratory Pressure 
PetCO2  Partial pressure of end-tidal carbon dioxide (mmHg) 
PetO2  Partial pressure of end-tidal oxygen (mmHg) 
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